Professor Robyn Ward

Braithwaite J; Ward RL; Marks D; Taylor N; Jackson N; Dick S; Wu C; Mullins J, 2013, Understanding Implementation: A Review of Literature and Models in Implementation Science, Quality and Safety, Original, Centre for Clinical Governance Research, Australian Institute of Health Innovation, Faculty of Medicine, University of New South Wales, Sydney NSW

Taylor I; Garcia-Aguilar ; Ward RL, 2010, Fast Facts: Colorectal Cancer, 3rd, Health Press

Siu LL; Lawler M; Haussler D; Knoppers BM; Lewin J; Vis DJ; Liao RG; Andre F; Banks I; Barrett JC; Caldas C; Camargo AA; Fitzgerald RC; Mao M; Mattison JE; Pao W; Sellers WR; Sullivan P; Teh BT; Ward RL; ZenKlusen JC; Sawyers CL; Voest EE, 2018, 'Facilitating a culture of responsible and effective sharing of cancer genome data', in Getting to Good: Research Integrity in the Biomedical Sciences, pp. 539 - 548, http://dx.doi.org/10.1038/nm.4089

Ward R; Ginsburg GS, 2017, 'Chapter 7 Local and Global Challenges in the Clinical Implementation of Precision Medicine', in Genomic and Precision Medicine, Elsevier, pp. 105 - 117, http://dx.doi.org/10.1016/b978-0-12-800681-8.00007-4

Ward R; Ginsburg GS, 2017, 'Local and Global Challenges in the Clinical Implementation of Precision Medicine', in Genomic and Precision Medicine: Foundations, Translation, and Implementation: Third Edition, pp. 105 - 117, http://dx.doi.org/10.1016/B978-0-12-800681-8.00007-4

Liu J; Ward RL, 2010, 'Folate and one-carbon metabolism and its impact on aberrant DNA methylation in cancer', in Herceg Z; Ushijima T (ed.), Advances in Genetics, Elsevier Inc, Burlington, pp. 79 - 122, http://dx.doi.org/10.1016/B978-0-12-380864-6.00004-3

Ward RL; Trainer A, 2009, 'Hereditary mutations and cancer management', in Robotin M; Olver I; Girgis A (ed.), When Cancer Crosses Disciplines A Physicians Handbook, World Scientific Publishing Co. Inc, USA, pp. 981 - 1004, http://dx.doi.org/10.1142/9781848163652_0041

Kang YJ; Caruana M; McLoughlin K; Killen J; Simms K; Taylor N; Frayling IM; Coupé VMH; Boussioutas A; Trainer AH; Ward RL; Macrae F; Canfell K, 2022, 'The predicted effect and cost-effectiveness of tailoring colonoscopic surveillance according to mismatch repair gene in patients with Lynch syndrome', Genetics in Medicine, vol. 24, pp. 1831 - 1846, http://dx.doi.org/10.1016/j.gim.2022.05.016

Meagher NS; Gorringe KL; Wakefield M; Bolithon A; Pang CNI; Chiu DS; Anglesio MS; Mallitt K-A; Doherty JA; Harris HR; Schildkraut JM; Berchuck A; Cushing-Haugen KL; Chezar K; Chou A; Tan A; Alsop J; Barlow E; Beckmann MW; Boros J; Bowtell DDL; AOCS Group ; Brand AH; Brenton JD; Campbell I; Cheasley D; Cohen J; Cybulski C; Elishaev E; Erber R; Farrell R; Fischer A; Fu Z; Gilks B; Gill AJ; Australian Pancreatic Genome Initiative ; Gourley C; Grube M; Harnett PR; Hartmann A; Hettiaratchi A; Høgdall CK; Huzarski T; Jakubowska A; Jimenez-Linan M; Kennedy CJ; Kim B-G; Kim J-W; Kim J-H; Klett K; Koziak JM; Lai T; Laslavic A; Lester J; Leung Y; Li N; Liauw W; Lim BWX; Linder A; Lubiński J; Mahale S; Mateoiu C; McInerny S; Menkiszak J; Minoo P; Mittelstadt S; Morris D; Orsulic S; Park S-Y; Pearce CL; Pearson JV; Pike MC; Quinn CM; Mohan GR; Rao J; Riggan MJ; Ruebner M; Salfinger S; Scott CL; Shah M; Steed H; Stewart CJR; Subramanian D; Sung S; Tang K; Timpson P; Ward RL; Wiedenhoefer R; Thorne H; kConFab Investigators ; Cohen PA; Crowe P; Fasching PA; Gronwald J; Hawkins NJ; Høgdall E; Huntsman DG; James PA; Karlan BY; Kelemen LE; Kommoss S; Konecny GE; Modugno F; Park SK; Staebler A; Sundfeldt K; Wu AH; Talhouk A; Pharoah PDP; Anderson L; DeFazio A; Köbel M; Friedlander ML; Ramus SJ, 2022, 'Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.', Clin Cancer Res, vol. 28, pp. 5383 - 5395, http://dx.doi.org/10.1158/1078-0432.CCR-22-1206

Morrell S; Kohonen-Corish MRJ; Ward RL; Sorrell TC; Roder D; Currow DC, 2022, 'Antibiotic exposure within six months before systemic therapy was associated with lower cancer survival', Journal of Clinical Epidemiology, vol. 147, pp. 122 - 131, http://dx.doi.org/10.1016/j.jclinepi.2022.04.003

Nic Giolla Easpaig B; Tran Y; Winata T; Lamprell K; Fajardo Pulido D; Arnolda G; Delaney GP; Liauw W; Smith K; Avery S; Rigg K; Westbrook J; Olver I; Currow D; Karnon J; Ward RL; Braithwaite J, 2022, 'The complexities, coordination, culture and capacities that characterise the delivery of oncology services in the common areas of ambulatory settings', BMC Health Services Research, vol. 22, pp. 190, http://dx.doi.org/10.1186/s12913-022-07593-3

Norris S; Belcher A; Howard K; Ward RL, 2022, 'Evaluating genetic and genomic tests for heritable conditions in Australia: lessons learnt from health technology assessments', Journal of Community Genetics, vol. 13, pp. 503 - 522, http://dx.doi.org/10.1007/s12687-021-00551-2

Gray J; Sullivan T; Latimer NR; Salter A; Sorich MJ; Ward RL; Karnon J, 2021, 'Extrapolation of Survival Curves Using Standard Parametric Models and Flexible Parametric Spline Models: Comparisons in Large Registry Cohorts with Advanced Cancer', Medical Decision Making, vol. 41, pp. 179 - 193, http://dx.doi.org/10.1177/0272989X20978958

Latimer NR; Pollard D; Towse A; Henshall C; Sansom L; Ward RL; Bruce A; Deakin C, 2021, 'Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi‐stakeholder, international workshop', BMC Health Services Research, vol. 21, http://dx.doi.org/10.1186/s12913-021-06425-0

Meiser B; Kaur R; Morrow A; Peate M; Wong WKT; McPike E; Cops E; Nichols C; Austin R; Fine M; Thrupp L; Ward R; Macrae F; Hiller JE; Trainer AH; Mitchell G; Susman R; Pachter N; Goodwin A; James PA; Mascarenhas L; Morton C; Shanley S; Young MA; Andrews L; Morrow EA; Tucker K; Lindeman G; Mascarenhas L; Morton C; Field M; Goodwin A; Monnik M; Poplawski N; Delatycki M; John T; Harris M; Kerr R; Vora B, 2021, 'Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice', Hereditary Cancer in Clinical Practice, vol. 19, pp. 24, http://dx.doi.org/10.1186/s13053-021-00180-3

Nic Giolla Easpaig B; Tran Y; Winata T; Lamprell K; Fajardo Pulido D; Arnolda G; Delaney GP; Liauw W; Smith K; Avery S; Rigg K; Westbrook J; Olver I; Currow D; Girgis A; Karnon J; Ward RL; Braithwaite J, 2021, 'Providing outpatient cancer care for CALD patients: a qualitative study', BMC Research Notes, vol. 14, http://dx.doi.org/10.1186/s13104-021-05724-3

Tudini E; Davidson AL; Dressel U; Andrews L; Antill Y; Crook A; Field M; Gattas M; Harris R; Kirk J; Pachter N; Salmon L; Susman R; Townshend S; Trainer AH; Tucker KM; Mitchell G; James PA; Ward RL; Mar Fan H; Poplawski NK; Spurdle AB, 2021, 'Implementing gene curation for hereditary cancer susceptibility in Australia: Achieving consensus on genes with clinical utility', Journal of Medical Genetics, vol. 58, pp. 853 - 858, http://dx.doi.org/10.1136/jmedgenet-2020-107140

Vidgen ME; Williamson D; Cutler K; McCafferty C; Ward RL; McNeil K; Waddell N; Bunker D, 2021, 'Queensland Genomics: an adaptive approach for integrating genomics into a public healthcare system', npj Genomic Medicine, vol. 6, pp. 71, http://dx.doi.org/10.1038/s41525-021-00234-4

Win AK; Dowty JG; Reece JC; Lee G; Templeton AS; Plazzer JP; Buchanan DD; Akagi K; Aksoy S; Alonso A; Alvarez K; Amor DJ; Ankathil R; Aretz S; Arnold JL; Aronson M; Austin R; Backman AS; Bajwa-ten Broeke SW; Barca-Tierno V; Barwell J; Bernstein I; Berthet P; Betz B; Bignon YJ; Boisjoli T; Bonadona V; Briollais L; Brunet J; Bucksch K; Buecher B; Buettner R; Burn J; Caldés T; Capella G; Caron O; Casey G; Chew MH; Choi YH; Church J; Clendenning M; Colas C; Cops EJ; Coupier I; Cruz-Correa M; de la Chapelle A; de Wind N; Dębniak T; Della Valle A; Delnatte C; Dhooge M; Dominguez-Valentin M; Drouet Y; Duijkers FA; Engel C; Esperon P; Evans DG; Falcón de Vargas A; Figueiredo JC; Foulkes W; Fourme E; Frebourg T; Gallinger S; Garre P; Genuardi M; Gerdes AM; Gima LM; Giraud S; Goodwin A; Görgens H; Green K; Guillem J; Guillén-Ponce C; Guimbaud R; Guindalini RSC; Half EE; Hall MJ; Hampel H; Hansen TVO; Heinimann K; Hes FJ; Hill J; Ho JWC; Holinski-Feder E; Hoogerbrugge N; Hüneburg R; Huntley V; James PA; Jensen UB; John T; Juhari WKW; Kalady M; Kastrinos F; Kloor M; Kohonen-Corish MR; Krogh LN; Kupfer SS; Ladabaum U; Lagerstedt-Robinson K; Lalloo F, 2021, 'Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study', The Lancet Oncology, vol. 22, pp. 1014 - 1022, http://dx.doi.org/10.1016/S1470-2045(21)00189-3

Ali A; Dumbrava M; Riddell K; Stewart N; Ward R; Ibrahim AK; Chin M, 2020, 'Correlation between initial tumour volume and treatment duration on Dabrafenib: Observation study of subjects with BRAF mutant melanoma on the BRF112680 trial', BMC Cancer, vol. 20, pp. 342, http://dx.doi.org/10.1186/s12885-020-06848-8

Belcher A; Ginsburg GS; Ward R, 2020, 'Global approaches to genomic medicine implementation', Science Translational Medicine, vol. 12, http://dx.doi.org/10.1126/scitranslmed.aax0911

Feletto E; Lew JB; Worthington J; He E; Caruana M; Butler K; Hui H; Taylor N; Banks E; Barclay K; Broun K; Butt A; Carter R; Cuff J; Dessaix A; Ee H; Emery J; Frayling IM; Grogan P; Holden C; Horn C; Jenkins MA; Kench JG; Laaksonen MA; Leggett B; Mitchell G; Morris S; Parkinson B; St John DJ; Taoube L; Tucker K; Wakefield MA; Ward RL; Win AK; Worthley DL; Armstrong BK; MacRae FA; Canfell K, 2020, 'Pathways to a cancer-free future: A protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia', BMJ Open, vol. 10, pp. e036475, http://dx.doi.org/10.1136/bmjopen-2019-036475

Kang YJ; Killen J; Caruana M; Simms K; Taylor N; Frayling IM; Snowsill T; Huxley N; Coupe VMH; Hughes S; Freeman V; Boussioutas A; Trainer AH; Ward RL; Mitchell G; Macrae FA; Canfell K, 2020, 'The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome', Medical Journal of Australia, vol. 212, pp. 72 - 81, http://dx.doi.org/10.5694/mja2.50356

Meiser B; Kaur R; Kirk J; Morrow A; Peate M; Wong WKT; McPike E; Cops E; Dowson C; Austin R; Fine M; Thrupp L; Ward R; Macrae F; Hiller JE; Trainer AH; Mitchell G; Susman R; Pachter N; Goodwin A; James P; Mascarenhas L; Morton C; Shanley S; Young MA; Andrews L; Morrow EA; Tucker K; Lindeman G; Field M; Monnik M; Poplawski N; Delatycki M; John T; Harris M; Kerr R; Vora B, 2020, 'Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics', Familial Cancer, vol. 19, pp. 337 - 346, http://dx.doi.org/10.1007/s10689-020-00183-4

Schaffer AL; Pearson SA; Perez-Concha O; Dobbins T; Ward RL; Leeuwen MTV; Rhee JJ; Laaksonen MA; Craigen G; Vajdic CM, 2020, 'Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP)', PLoS ONE, vol. 15, pp. e0230373, http://dx.doi.org/10.1371/journal.pone.0230373

Williams DS; Mouradov D; Newman MR; Amini E; Nickless DK; Fang CG; Palmieri M; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Skinner I; Jones I; Gibbs P; Sieber OM, 2020, 'Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation', Modern Pathology, vol. 33, pp. 1420 - 1432, http://dx.doi.org/10.1038/s41379-020-0496-1

Bancroft EK; Saya S; Page EC; Myhill K; Thomas S; Pope J; Chamberlain A; Hart R; Glover W; Cook J; Rosario DJ; Helfand BT; Selkirk CH; Davidson R; Longmuir M; Eccles DM; Gadea N; Brewer C; Barwell J; Salinas M; Greenhalgh L; Tischkowitz M; Henderson A; Evans DG; Buys SS; Eeles RA; Aaronson NK; Eeles R; Bancroft E; Page E; Kote-Jarai Z; Ardern-Jones A; Bangma C; Castro E; Dearnaley D; Falconer A; Foster C; Gronberg H; Hamdy FC; Johannsson OT; Khoo V; Eccles D; Lilja H; Evans G; Eyfjord J; Lubinski J; Maehle L; Mikropoulos C; Millner A; Mitra A; Offman J; Moynihan C; Rennert G; Suri M; Dias A; Taylor N; D'Mello L; Pope J; James P; Mitchell G; Shanley S; Richardson K; McKinley J; Petelin L; Murphy M; Mascarenhas L; Murphy D; Lam J; Taylor L; Miller C; Stapleton A; Chong M; Suthers G; Poplawski N; Tucker K; Andrews L; Duffy J; Millard R; Ward R; Williams R; Stricker P; Kirk J; Bowman M; Patel M; Harris M; O'Connell S; Hunt C; Smyth C; Frydenberg M; Lindeman G; Shackleton K; Morton C; Susman R; McGaughran J; Boon M; Pachter N; Townshend S; Schofield L; Nicholls C; Spigelman A; Gleeson M; Amor D; Burke J; Patterson B; Swindle P; Scott R; Foulkes W; Boshari T; Aprikian A; Jensen T; Bojeson A; Osther P; Skytte A-B; Cruger D; Tondering MK; Gerdes A-M; Schmutzler R; Rhiem K; Wihler P; Kast K; Griebsch C; Johannsson O; Stefansdottir V; Murthy V; Sarin R; Awatagiri K; Ghonge S; Kowtal P; Mulgund G; Gallagher D; Bambury R; Farrell M; Gallagher F; Kiernan I; Friedman E; Chen-Shtoyerman R; Basevitch A; Leibovici D; Melzer E; Ben-Yehoshua SJ; Nicolai N; Radice P; Valdagni R; Magnani T; Gay S; Teo SH; Tan HM; Yoon S-Y; Thong MK; Vasen H; Ringleberg J; van Asperen C; Kiemeney B; van Zelst-Stams W; Ausems MGEM; van der Luijt RB; van Os T; Ruijs MWG; Adank MA; Oldenburg RA; Helderman-van den Enden APTJM; Caanen BAH; Oosterwijk JC; Moller P; Brennhovd B; Medvik H; Hanslien E; Grindedal EM; Cybulski C; Wokolorczyk D; Teixeira M; Maia S; Peixoto A; Henrique R; Oliveira J; Goncalves N; Araujo L; Seixas M; Souto JP; Nogueira P; Copakova L; Zgajnar J; Krajc M; Vrecar A; Capella G; Ramon y Cajal T; Fisas D; Mora J; Esquena S; Balmana J; Morote J; Liljegren A; Hjalm-Eriksson M; Ekdahl K-J; Carlsson S; George A; Kemp Z; Wiggins J; Moss C; Van As N; Thompson A; Ogden C; Woodhouse C; Kumar P; Evans DG; Bulman B; Rothwell J; Tricker K; Wise G; Mercer C; McBride D; Costello P; Pearce A; Torokwa A; Paterson J; Clowes V; Taylor A; Newcombe B; Walker L; Halliday D; Stayner B; Fleming-Brown D; Snape K; Hanson H; Hodgson S; Brice G; Homfray T; Hammond C; Kohut K; Anjum U; Dearing A; Mencias M; Potter A; Renton C; Searle A; Hill K; Goodman S; Garcia L; Devlin G; Everest S; Nadolski M; Douglas F; Jobson I; Paez E; Donaldson A; Tomkins S; Langman C; Jacobs C; Pichert G; Shaw A; Kulkarni A; Tripathi V; Rose S; Compton C; Watson M; Reinholtz C; Brady A; Dorkins H; Melville A; Kosicka-Slawinska M; Cummings C; Kiesel V; Bartlett M; Randhawa K; Ellery N; Side L; Male A; Simon K; Rees K; Tidey L; Gurasashvili J; Nevitt L; Ingram S; Howell A; Rosario D; Catto J; Howson J; Ong K-R; Chapman C; Cole T; Heaton T; Hoffman J; Burgess L; Huber C; Islam F; Watt C; Duncan A; Kockelbergh R; Mzazi S; Dineen A; Sattar A; Kaemba B; Sidat Z; Patel N; Siguake K; Birt A; Poultney U; Umez-Eronini N; Mom J; Sutton V; Cornford P; Bermingham N; Yesildag P; Treherne K; Griffiths J; Cogley L; Gott H; Rubinstein WS; Hulick P; McGuire M; Shevrin D; Kaul K; Weissman S; Newlin A; Vogel K; Weiss S; Hook N; Buys S; Goldgar D; Conner T; Venne V; Stephenson R; Dechet C; Domchek S; Powers J; Rustgi N; Strom S; Arun B; Davis JW; Yamamura Y; Obeid E; Giri V; Gross L; Bealin L; Cooney K; Stoffel E; Okoth L, 2019, 'Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations', BJU INTERNATIONAL, vol. 123, pp. 284 - 292, http://dx.doi.org/10.1111/bju.14412

He E; Alison R; Blanks R; Pirie K; Reeves G; Ward RL; Steele R; Patnick J; Canfell K; Beral V; Green J, 2019, 'Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: A large prospective study of women in England', International Journal of Epidemiology, vol. 48, pp. 549 - 558, http://dx.doi.org/10.1093/ije/dyy271

Jorissen RN; Croxford M; Jones IT; Ward RL; Hawkins NJ; Gibbs P; Sieber OM, 2019, 'Evaluation of the transferability of survival calculators for stage II/III colon cancer across healthcare systems', International Journal of Cancer, vol. 145, pp. 132 - 142, http://dx.doi.org/10.1002/ijc.32100

Nic Giolla Easpaig B; Arnolda G; Tran Y; Bierbaum M; Lamprell K; Delaney GP; Liauw W; Chittajallu R; Winata T; Ward RL; Currow DC; Olver I; Karnon J; Westbrook J; Braithwaite J, 2019, 'What is multidisciplinary cancer care like in practice? a protocol for a mixed-method study to characterise ambulatory oncology services in the Australian public sector', BMJ Open, vol. 9, pp. e031179, http://dx.doi.org/10.1136/bmjopen-2019-031179

Poulos RC; Perera D; Packham D; Shah A; Janitz C; Pimanda JE; Hawkins N; Ward RL; Hesson LB; Wong JWH, 2019, 'Scarcity of Recurrent Regulatory Driver Mutations in Colorectal Cancer Revealed by Targeted Deep Sequencing', JNCI CANCER SPECTRUM, vol. 3, http://dx.doi.org/10.1093/jncics/pkz012

Vajdic CM; Perez-Concha O; Dobbins T; Ward RL; Schaffer AL; van Leeuwen MT; Rhee JJ; Laaksonen MA; Craigen G; Pearson SA, 2019, 'Demographic, social and lifestyle risk factors for cancer registry-notified cancer of unknown primary site (CUP)', Cancer Epidemiology, vol. 60, pp. 156 - 161, http://dx.doi.org/10.1016/j.canep.2019.04.004

Vajdic CM; Perez-Concha O; Rhee JJ; Dobbins T; Ward RL; Schaffer AL; van Leeuwen MT; Laaksonen MA; Craigen G; Pearson SA, 2019, 'Health-related predictors of cancer registry-notified cancer of unknown primary site (CUP)', Cancer Epidemiology, vol. 61, pp. 1 - 7, http://dx.doi.org/10.1016/j.canep.2019.05.001

Williams DS; Mouradov D; Jorissen RN; Newman MR; Amini E; Nickless DK; Teague JA; Fang CG; Palmieri M; Parsons MJ; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Faragher I; Jones IT; Gibbs P; Sieber OM, 2019, 'Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes', Gut, vol. 68, pp. 465 - 474, http://dx.doi.org/10.1136/gutjnl-2017-315664

Daniels B; Kiely BE; Houssami N; Lord SJ; Dobbins T; Lu CY; Ward RL; Pearson SA, 2018, 'Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: A national population-based observational study (2006-2014)', British Journal of Cancer, vol. 118, pp. 441 - 447, http://dx.doi.org/10.1038/bjc.2017.405

Daniels B; Kiely BE; Lord SJ; Houssami N; Lu CY; Ward RL; Pearson SA, 2018, 'Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001–2016)', Breast Cancer Research and Treatment, vol. 171, pp. 151 - 159, http://dx.doi.org/10.1007/s10549-018-4804-0

Daniels B; Kiely BE; Lord SJ; Houssami N; Lu CY; Ward RL; Pearson SA, 2018, 'Trastuzumab for metastatic breast cancer: Real world outcomes from an Australian whole-of-population cohort (2001–2016)', Breast, vol. 38, pp. 7 - 13, http://dx.doi.org/10.1016/j.breast.2017.11.007

Domingo E; Camps C; Kaisaki PJ; Parsons MJ; Mouradov D; Pentony MM; Makino S; Palmieri M; Ward RL; Hawkins NJ; Gibbs P; Askautrud H; Oukrif D; Wang H; Wood J; Tomlinson E; Bark Y; Kaur K; Johnstone EC; Palles C; Church DN; Novelli M; Danielsen HE; Sherlock J; Kerr D; Kerr R; Sieber O; Taylor JC; Tomlinson I, 2018, 'Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series', The Lancet Gastroenterology and Hepatology, vol. 3, pp. 635 - 643, http://dx.doi.org/10.1016/S2468-1253(18)30117-1

He E; Lew JB; Egger S; Banks E; Ward RL; Beral V; Canfell K, 2018, 'Factors associated with participation in colorectal cancer screening in Australia: Results from the 45 and Up Study cohort', Preventive Medicine, vol. 106, pp. 185 - 193, http://dx.doi.org/10.1016/j.ypmed.2017.10.032

Liu Q; Thoms JAI; Nunez AC; Huang Y; Knezevic K; Packham D; Poulos RC; Williams R; Beck D; Hawkins NJ; Ward RL; Wong JWH; Hesson LB; Sloane MA; Pimanda JE, 2018, 'Disruption of a 35 KB enhancer impairs CTCF binding and MLH1 expression in colorectal cells', Clinical Cancer Research, vol. 24, pp. 4602 - 4611, http://dx.doi.org/10.1158/1078-0432.CCR-17-3678

Loke LPY; Chen TYT; Lewis CR; Ward RL; Rushton SA; Shapiro JD, 2018, 'Quality and impact of eviQ Cancer Treatments Online (www.eviq.org.au): the medical oncologist's perspective', Asia-Pacific Journal of Clinical Oncology, vol. 14, pp. e203 - e210, http://dx.doi.org/10.1111/ajco.12689

Mascarenhas L; Shanley S; Mitchell G; Spurdle AB; Macrae F; Pachter N; Buchanan DD; Ward RL; Fox S; Duxbury E; Driessen R; Boussioutas A, 2018, 'Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providers', Asia-Pacific Journal of Clinical Oncology, vol. 14, pp. 417 - 425, http://dx.doi.org/10.1111/ajco.13076

Morris MJ; Hesson LB; Poulos RC; Ward RL; Wong JWH; Youngson NA, 2018, 'Reduced nuclear DNA methylation and mitochondrial transcript changes in adenomas do not associate with mtDNA methylation', Biomarker Research, vol. 6, pp. 37, http://dx.doi.org/10.1186/s40364-018-0151-x

Sakthianandeswaren A; Parsons MJ; Mouradov D; Mackinnon RN; Catimel B; Liu S; Palmieri M; Love C; Jorissen RN; Li S; Whitehead L; Putoczki TL; Preaudet A; Tsui C; Nowell CJ; Ward RL; Hawkins NJ; Desai J; Gibbs P; Ernst M; Street I; Buchert M; Sieber OM, 2018, 'MACROD2 haploinsufficiency impairs catalytic activity of PARP1 and promotes chromosome instability and growth of intestinal tumors', Cancer Discovery, vol. 8, pp. 988 - 1005, http://dx.doi.org/10.1158/2159-8290.CD-17-0909

Tan SYS; O’Neill S; Goldstein D; Ward RL; Daniels B; Vajdic CM, 2018, 'Predictors of care for patients with cancer of unknown primary site in three Australian hospitals', Asia-Pacific Journal of Clinical Oncology, vol. 14, pp. e512 - e520, http://dx.doi.org/10.1111/ajco.12815

Tuffaha HW; Mitchell A; Ward RL; Connelly L; Butler JRG; Norris S; Scuffham PA, 2018, 'Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers', Genetics in Medicine, vol. 20, pp. 985 - 994, http://dx.doi.org/10.1038/gim.2017.231

Daniels B; Lord SJ; Kiely BE; Houssami N; Haywood P; Lu CY; Ward RL; Pearson SA, 2017, 'Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: Protocol detailing observations in a whole of population cohort', BMJ Open, vol. 7, http://dx.doi.org/10.1136/bmjopen-2016-014439

Doust J; Vandvik PO; Qaseem A; Mustafa RA; Horvath AR; Frances A; Al-Ansary L; Bossuyt P; Ward RL; Kopp I; Gollogly L; Schunemann H; Glasziou P, 2017, 'Guidance for modifying the definition of diseases: A checklist', JAMA Internal Medicine, vol. 177, pp. 1020 - 1025, http://dx.doi.org/10.1001/jamainternmed.2017.1302

Harris CA; Daniels BJ; Ward RL; Pearson SA, 2017, 'Retrospective comparison of Australia’s Pharmaceutical Benefits Scheme claims data with prescription data in HER2 positive early breast cancer patients (2008-2012)', Public Health Research and Practice, vol. 27, http://dx.doi.org/10.17061/phrp2751744

Liang R; Meiser B; Smith S; Kasparian NA; Lewis CR; Chin M; Long GV; Ward R; Menzies AM; Harris-Wai JN; Kaur R, 2017, 'Advanced cancer patients’ attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study', European Journal of Cancer Care, vol. 26, http://dx.doi.org/10.1111/ecc.12600

Ma SSQ; Henry CE; Llamosas E; Higgins R; Daniels B; Hesson LB; Hawkins NJ; Ward RL; Ford CE, 2017, 'Validation of specificity of antibodies for immunohistochemistry: the case of ROR2', Virchows Archiv : an international journal of pathology, vol. 470, pp. 99 - 108, http://dx.doi.org/10.1007/s00428-016-2019-5

Pearce A; Haas M; Viney R; Pearson SA; Haywood P; Brown C; Ward R, 2017, 'Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0184360

Vis DJ; Lewin J; Liao RG; Mao M; Andre F; Ward RL; Calvo F; Teh BT; Camargo AA; Knoppers BM; Sawyers CL; Wessels LFA; Lawler M; Siu LL; Voest E, 2017, 'Towards a global cancer knowledge network: dissecting the current international cancer genomic sequencing landscape', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 28, pp. 1145 - 1151, http://dx.doi.org/10.1093/annonc/mdx037

Chandrakanthan V; Yeola A; Kwan JC; Oliver RA; Qiao Q; Kang YC; Zarzour P; Beck D; Boelen L; Unnikrishnan A; Villanueva JE; Nunez AC; Knezevic K; Palu C; Nasrallah R; Carnell M; Macmillan A; Whan R; Yu Y; Hardy P; Grey ST; Gladbach A; Delerue F; Ittner L; Mobbs R; Walkley CR; Purton LE; Ward RL; Wong JWH; Hesson LB; Walsh W; Pimanda JE, 2016, 'Pdgf-ab and 5-Azacytidine induce conversion of somatic cells into tissue-regenerative multipotent stem cells', Proceedings of the National Academy of Sciences of the United States of America, vol. 113, pp. E2306 - E2315, http://dx.doi.org/10.1073/pnas.1518244113

Chen Y; Peate M; Kaur R; Meiser B; Wong T; Kirk J; Ward R; Goodwin A; Macrae F; Hiller J; Trainer A; Mitchell G, 2016, 'Exploring clinicians’ attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer', Familial Cancer, vol. 16, pp. 99 - 109, http://dx.doi.org/10.1007/s10689-016-9933-1

He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL, 2016, 'The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study', ONCOLOGIST, vol. 21, pp. 618 - 625, http://dx.doi.org/10.1634/theoncologist.2015-0530

He EY; Wyld L; Sloane MA; Canfell K; Ward RL, 2016, 'The molecular characteristics of colonic neoplasms in serrated polyposis: a systematic review and meta-analysis', Journal of Pathology: Clinical Research, vol. 2, pp. 127 - 137, http://dx.doi.org/10.1002/cjp2.44

He EYJ; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL, 2016, 'The impact of mismatch repair status in colorectal cancer on the decision to treat with adjuvant chemotherapy: An Australian population-based multicenter study', Oncologist, vol. 21, pp. 618 - 625, http://dx.doi.org/10.1634/theoncologist.2015-0530

Henshall C; Latimer NR; Sansom L; Ward RL, 2016, 'Treatment switching in cancer trials: Issues and proposals', International Journal of Technology Assessment in Health Care, vol. 32, pp. 167 - 174, http://dx.doi.org/10.1017/S026646231600009X

Hesson LB; Ng B; Zarzour P; Srivastava S; Kwok CT; Packham D; Nunez AC; Beck D; Ryan R; Dower A; Ford CE; Pimanda JE; Sloane MA; Hawkins NJ; Bourke MJ; Wong JWH; Ward RL, 2016, 'Integrated genetic, epigenetic, and transcriptional profiling identifies molecular pathways in the development of laterally spreading tumors', Molecular Cancer Research, vol. 14, pp. 1217 - 1228, http://dx.doi.org/10.1158/1541-7786.MCR-16-0175

Kuroiwa-Trzmielina J; Wang F; Rapkins RW; Ward RL; Buchanan DD; Win AK; Clendenning M; Rosty C; Southey MC; Winship IM; Hopper JL; Jenkins MA; Olivier J; Hawkins NJ; Hitchins MP, 2016, 'SNP rs16906252C>T is an expression and methylation quantitative trait locus associated with an increased risk of developing MGMT-methylated colorectal cancer', Clinical Cancer Research, vol. 22, pp. 6266 - 6277, http://dx.doi.org/10.1158/1078-0432.CCR-15-2765

Liu Q; Hesson LB; Nunez AC; Packham D; Hawkins NJ; Ward RL; Sloane MA, 2016, 'Pathogenic germline MCM9 variants are rare in Australian Lynch-like syndrome patients', Cancer Genetics, vol. 209, pp. 497 - 500, http://dx.doi.org/10.1016/j.cancergen.2016.10.001

Liu Q; Hesson LB; Nunez AC; Packham D; Williams R; Ward RL; Sloane MA, 2016, 'A cryptic paracentric inversion of MSH2 exons 2-6 causes Lynch syndrome', Carcinogenesis, vol. 37, pp. 10 - 17, http://dx.doi.org/10.1093/carcin/bgv154

Liu Q; Thompson BA; Ward RL; Hesson LB; Sloane MA, 2016, 'Understanding the Pathogenicity of Noncoding Mismatch Repair Gene Promoter Variants in Lynch Syndrome', Human Mutation, vol. 37, pp. 417 - 426, http://dx.doi.org/10.1002/humu.22971

Loke LPY; Chen TYT; Lewis CR; Ward RL; Rushton SA; Shapiro JD, 2016, 'Quality and impact of eviQ Cancer Treatments Online: The medical oncologist's perspective.', Journal of Clinical Oncology, vol. 34, pp. e18214 - e18214, http://dx.doi.org/10.1200/jco.2016.34.15_suppl.e18214

Ma S; srivastava S; llamosas E; hawkins N; hesson L; ward R; Ford C, 2016, 'ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.', BMC Cancer, vol. 16, http://dx.doi.org/10.1186/s12885-016-2576-7

Ma SSQ; Henry CE; Llamosas E; Higgins R; Daniels B; Hesson LB; Hawkins NJ; Ward RL; Ford CE, 2016, 'Erratum to: Validation of specificity of antibodies for immunohistochemistry: the case of ROR2 (Virchows Archiv, (2016), 10.1007/s00428-016-2019-5)', Virchows Archiv, vol. 469, pp. 717, http://dx.doi.org/10.1007/s00428-016-2036-4

Malaterre J; Pereira L; Putoczki T; Millen R; Paquet-Fifield S; Germann M; Liu J; Cheasley D; Sampurno S; Stacker SA; Achen MG; Ward RL; Waring P; Mantamadiotis T; Ernst M; Ramsay RG, 2016, 'Intestinal-specific activatable Myb initiates colon tumorigenesis in mice', Oncogene, vol. 35, pp. 2475 - 2484, http://dx.doi.org/10.1038/onc.2015.305

Manolio TA; Ward R; Ginsburg GS, 2016, 'Clinical implementation of genomic medicine: the importance of global collaboration', Expert Review of Precision Medicine and Drug Development, vol. 1, pp. 349 - 351, http://dx.doi.org/10.1080/23808993.2016.1192460

Pelttari LM; Khan S; Vuorela M; Kiiski JI; Vilske S; Nevanlinna V; Ranta S; Schleutker J; Winqvist R; Kallioniemi A; Dörk T; Bogdanova NV; Figueroa J; Pharoah PDP; Schmidt MK; Dunning AM; García-Closas M; Bolla MK; Dennis J; Michailidou K; Wang Q; Hopper JL; Southey MC; Rosenberg EH; Fasching PA; Beckmann MW; Peto J; Dos-Santos-silva I; Sawyer EJ; Tomlinson I; Burwinkel B; Surowy H; Guénel P; Truong T; Bojesen SE; Nordestgaard BG; Benitez J; González-Neira A; Neuhausen SL; Anton-Culver H; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Brüning T; Lindblom A; Margolin S; Mannermaa A; Hartikainen JM; Chenevix-Trench G; Van Dyck L; Janssen H; Chang-Claude J; Rudolph A; Radice P; Peterlongo P; Hallberg E; Olson JE; Giles GG; Milne RL; Haiman CA; Schumacher F; Simard J; Dumont M; Kristensen V; Borresen-Dale AL; Zheng W; Beeghly-Fadiel A; Grip M; Andrulis IL; Glendon G; Devilee P; Seynaeve C; Hooning MJ; Collée M; Cox A; Cross SS; Shah M; Luben RN; Hamann U; Torres D; Jakubowska A; Lubinski J; Couch FJ; Yannoukakos D; Orr N; Swerdlow A; Darabi H; Li J; Czene K; Hall P; Easton DF; Mattson J; Blomqvist C; Aittomäki K; Nevanlinna H; Aghmesheh M; Amor D; Andrews L, 2016, 'RAD51B in familial breast cancer', PLoS ONE, vol. 11, http://dx.doi.org/10.1371/journal.pone.0153788

Schofield PE; Stockler MR; Zannino D; Tebbutt NC; Price TJ; Simes RJ; Wong N; Pavlakis N; Ransom D; Moylan E; Underhill C; Wyld D; Burns I; Ward R; Wilcken N; Jefford M, 2016, 'Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer', Supportive Care in Cancer, vol. 24, pp. 401 - 408, http://dx.doi.org/10.1007/s00520-015-2792-8

Siu LL; Lawler M; Haussler D; Knoppers BM; Lewin J; Vis DJ; Liao RG; Andre F; Banks I; Barrett JC; Caldas C; Camargo AA; Fitzgerald RC; Mao M; Mattison JE; Pao W; Sellers WR; Sullivan P; Teh BT; Ward RL; ZenKlusen JC; Sawyers CL; Voest EE, 2016, 'Facilitating a culture of responsible and effective sharing of cancer genome data', Nature Medicine, vol. 22, pp. 464 - 471, http://dx.doi.org/10.1038/nm.4089

Sloane MA; Ward RL; Hesson LB, 2016, 'Defining the criteria for identifying constitutional epimutations', Clinical Epigenetics, vol. 8, http://dx.doi.org/10.1186/s13148-016-0207-4

Suraweera N; Mouradov D; Li S; Jorissen RN; Hampson D; Ghosh A; Sengupta N; Thaha M; Ahmed S; Kirwan M; Aleva F; Propper D; Feakins RM; Vulliamy T; Elwood NJ; Tian P; Ward RL; Hawkins NJ; Xu ZZ; Molloy PL; Jones IT; Croxford M; Gibbs P; Silver A; Sieber OM, 2016, 'Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer', Oncotarget, vol. 7, pp. 36474 - 36488, http://dx.doi.org/10.18632/oncotarget.9015

Thoms JAI; Knezevic K; Liu JJ; Glaros EN; Thai T; Qiao Q; Campbell H; Packham D; Huang Y; Papathanasiou P; Tunningley R; Whittle B; Yeung AWS; Chandrakanthan V; Hesson L; Chen V; Wong JWH; Purton LE; Ward RL; Thomas SR; Pimanda JE, 2016, 'Arrested hematopoiesis and vascular relaxation defects in mice with a mutation in Dhfr', Molecular and Cellular Biology, vol. 36, pp. 1222 - 1236, http://dx.doi.org/10.1128/MCB.01035-15

Deb S; Xu H; Tuynman JB; George J; Yan Y; Li J; Ward R; Mortensen N; Hawkins N; McKay M; Ramsay RG; Fox SB, 2015, 'RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in kras mutant colorectal carcinomas', Pathology, vol. 47, pp. S53 - S54, http://dx.doi.org/10.1097/01.pat.0000461457.19279.a3

Frederix GWJ; Afzali HHA; Dasbach E; Ward RL, 2015, 'Development and use of disease-specific (reference) models for economic evaluations of health technologies: An overview of key issues and potential solutions', PharmacoEconomics, vol. In Press, pp. 777 - 781, http://dx.doi.org/10.1007/s40273-015-0274-y

Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C, 2015, 'Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion', Oncotarget, vol. 6, pp. 40310 - 40326, http://dx.doi.org/10.18632/oncotarget.5643

Henry C; Quadir A; Hawkins NJ; Jary E; Llamosas E; Kumar D; Daniels B; Ward RL; Ford CE, 2015, 'Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling', Journal of Cancer Research and Clinical Oncology, vol. 141, pp. 243 - 254, http://dx.doi.org/10.1007/s00432-014-1824-y

Hesson LB; Packham D; Kwok CT; Nunez AC; Ng B; Schmidt C; Fields M; Wong JW; Sloane MA; Ward RL, 2015, 'Lynch Syndrome associated with two MLH1 promoter variants and allelic imbalance of MLH1 expression.', Human Mutation, vol. 36, pp. 622 - 630, http://dx.doi.org/10.1002/humu.22785

Jorissen RN; Christie M; Mouradov D; Sakthianandeswaren A; Li S; Love C; Xu ZZ; Molloy PL; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Burgess AW; Busam D; Zhao Q; Strausberg RL; Lipton L; Desai J; Gibbs P; Sieber OM, 2015, 'Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer', British Journal of Cancer, vol. 113, pp. 979 - 988, http://dx.doi.org/10.1038/bjc.2015.296

Loke L; Ward R; Shapiro J; Lewis C; Rushton S; Rendel P, 2015, '514P eviQ Cancer Treatments Online (www.eviQ.org.au)- Use in Asia', Annals of Oncology, vol. 26, pp. ix156 - ix156, http://dx.doi.org/10.1093/annonc/mdv535.09

Manolio TA; Abramowicz M; Al-Mulla F; Anderson W; Balling R; Berger AC; Bleyl S; Chakravarti A; Chantratita W; Chisholm RL; Dissanayake VHW; Dunn M; Dzau VJ; Han BG; Hubbard T; Kolbe A; Korf B; Kubo M; Lasko P; Leego E; Mahasirimongkol S; Majumdar PP; Matthijs G; McLeod HL; Metspalu A; Meulien P; Miyano S; Naparstek Y; O'Rourke PP; Patrinos GP; Rehm HL; Relling MV; Rennert G; Rodriguez LL; Roden DM; Shuldiner AR; Sinha S; Tan P; Ulfendahl M; Ward R; Williams MS; Wong JEL; Green ED; Ginsburg GS, 2015, 'Global implementation of genomic medicine: We are not alone', Science Translational Medicine, vol. 7, http://dx.doi.org/10.1126/scitranslmed.aab0194

Pearce A; Haas M; Viney R; Haywood P; Pearson S-A; van Gool K; Srasuebkul P; Ward R, 2015, 'Can administrative data be used to measure chemotherapy side effects?', Expert Review of Pharmacoeconomics & Outcomes Research, vol. 15, pp. 215 - 222, http://dx.doi.org/10.1586/14737167.2015.990888

Schaffer AL; Pearson SA; Dobbins TA; Er CC; Ward RL; Vajdic CM, 2015, 'Patterns of care and survival after a cancer of unknown primary (CUP) diagnosis: A population-based nested cohort study in Australian Government Department of Veterans' Affairs clients', Cancer Epidemiology, vol. 39, pp. 578 - 584, http://dx.doi.org/10.1016/j.canep.2015.02.007

Scott GM; Hettiaratchi A; Salisbury E; Ward RL; Hawkins NJ, 2015, 'Institutional biobanking: An integral part of contemporary pathology practice', Pathology, vol. 47, pp. 4 - 6, http://dx.doi.org/10.1097/PAT.0000000000000185

Sloane MA; Nunez AC; Packham D; Kwok CT; Suthers G; Hesson LB; Ward RL, 2015, 'Mosaic epigenetic inheritance as a cause of early-onset colorectal cancer', JAMA Oncology, vol. 1, pp. 953 - 957, http://dx.doi.org/10.1001/jamaoncol.2015.1484

Vajdic CM; Ward RL, 2015, 'Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study in Australian Government Department of Veterans' Affairs client', Cancer Epidemiology, vol. 39, pp. 585 - 592, http://dx.doi.org/10.1016/j.canep.2015.02.006

Ward RL; Laaksonen MA; van Gool K; Pearson SA; Daniels B; Bastick P; Norman R; Hou C; Haywood P; Haas M, 2015, 'Cost of cancer care for patients undergoing chemotherapy: The elements of cancer care study', Asia-Pacific Journal of Clinical Oncology, vol. 11, pp. 178 - 186, http://dx.doi.org/10.1111/ajco.12354

Zarzour P; Boelen L; Luciani F; Beck D; Sakthianandeswaren A; Mouradov D; Sieber OM; Hawkins NJ; Hesson LB; Ward RL; Wong JWH, 2015, 'Single nucleotide polymorphism array profiling identifies distinct chromosomal aberration patterns across colorectal adenomas and carcinomas', Genes Chromosomes and Cancer, vol. 54, pp. 303 - 314, http://dx.doi.org/10.1002/gcc.22243

Bancroft EK; Page EC; Castro E; Lilja H; Vickers A; Sjoberg D; Assel M; Foster CS; Mitchell G; Drew K; Mæhle L; Axcrona K; Evans DG; Bulman B; Eccles D; McBride D; Van Asperen C; Vasen H; Kiemeney LA; Ringelberg J; Cybulski C; Wokolorczyk D; Selkirk C; Hulick PJ; Bojesen A; Skytte AB; Lam J; Taylor L; Oldenburg R; Cremers R; Verhaegh G; Van Zelst-Stams WA; Oosterwijk JC; Blanco I; Salinas M; Cook J; Rosario DJ; Buys S; Conner T; Ausems MG; Ong KR; Hoffman J; Domchek S; Powers J; Teixeira MR; Maia S; Foulkes WD; Taherian N; Ruijs M; Den Enden ATHV; Izatt L; Davidson R; Adank MA; Walker L; Schmutzler R; Tucker K; Kirk J; Hodgson S; Harris M; Douglas F; Lindeman GJ; Zgajnar J; Tischkowitz M; Clowes VE; Susman R; Ramón Y Cajal T; Patcher N; Gadea N; Spigelman A; Van Os T; Liljegren A; Side L; Brewer C; Brady AF; Donaldson A; Stefansdottir V; Friedman E; Chen-Shtoyerman R; Amor DJ; Copakova L; Barwell J; Giri VN; Murthy V; Nicolai N; Teo SH; Greenhalgh L; Strom S; Henderson A; McGrath J; Gallagher D; Aaronson N; Ardern-Jones A; Bangma C; Dearnaley D; Costello P; Eyfjord J; Rothwell J; Falconer A; Gronberg H; Hamdy FC, 2014, 'Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study', European Urology, vol. 66, pp. 489 - 499, http://dx.doi.org/10.1016/j.eururo.2014.01.003

Chin M; Ward RL, 2014, 'Targeting treatment for colorectal cancer: The EGFR antibody story', Cancer Forum, vol. 38, pp. 39 - 43

Deb S; Xu H; Tuynman J; George J; Yan Y; Li J; Ward RL; Mortensen N; Hawkins NJ; McKay MJ; Ramsay RG; Fox SB, 2014, 'RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas', British Journal of Cancer, vol. 110, pp. 1606 - 1613, http://dx.doi.org/10.1038/bjc.2014.31

Dewhurst SM; McGranahan N; Burrell RA; Rowan AJ; Grönroos E; Endesfelder D; Joshi T; Mouradov D; Gibbs P; Ward RL; Hawkins NJ; Szallasi Z; Sieber OM; Swanton C, 2014, 'Tolerance of whole- genome doubling propagates chromosomal instability and accelerates cancer genome evolution', Cancer Discovery, vol. 4, pp. 175 - 185, http://dx.doi.org/10.1158/2159-8290.CD-13-0285

Ford CE; Punnia-Moorthy G; Henry CE; Llamosas E; Nixdorf S; Olivier J; Caduff R; Ward RL; Heinzelmann-Schwarz V, 2014, 'The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer', Gynecologic Oncology, vol. 134, pp. 338 - 345, http://dx.doi.org/10.1016/j.ygyno.2014.06.004

Frayling I; Ward R, 2014, 'SHOULD WE CONSIDER INTRODUCING SYSTEMATIC SCREENING FOR LYNCH SYNDROME?', CANCER FORUM, vol. 38, pp. 229 - 232, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000213408300013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Frayling I; Ward R, 2014, 'Should we consider introducing systematic screening for lynch syndrome?', Cancer Forum, vol. 38, pp. 187 - 190

Hesson LB; Sloane MA; Wong JWH; Nunez AC; Srivastava S; Ng B; Hawkins NJ; Bourke MJ; Ward RL, 2014, 'Altered promoter nucleosome positioning is an early event in gene silencing', Epigenetics, vol. 9, pp. 1422 - 1430, http://dx.doi.org/10.4161/15592294.2014.970077

Hesson LB; Ward RL, 2014, 'Discrimination of pseudogene and parental gene dna methylation using allelic bisulfite sequencing', Methods in Molecular Biology, vol. 1167, pp. 265 - 274, http://dx.doi.org/10.1007/978-1-4939-0835-6_18

Hesson LB; Ward RL, 2014, 'The importance of distinguishing pseudogenes from parental genes', Clinical Epigenetics, vol. 6, pp. 90, http://dx.doi.org/10.1186/s13148-014-0033-5

Hillman RJ; Garland SM; Gunathilake MPW; Stevens M; Kumaradevan N; Lemech C; Ward RL; Meagher A; McHugh L; Jin F; Carroll S; Goldstein D; Grulich AE; Tabrizi SN, 2014, 'Human papillomavirus (HPV) genotypes in an Australian sample of anal cancers', International Journal of Cancer, vol. 135, pp. 996 - 1001, http://dx.doi.org/10.1002/ijc.28730

Jacob F; Hitchins MP; Fedier A; Brennan K; Nixdorf S; Hacker NF; Ward R; Heinzelmann-Schwarz VA, 2014, 'Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells', BMC Molecular Biology, vol. 15, http://dx.doi.org/10.1186/1471-2199-15-24

Jacob F; Hitchins MP; Fedier A; Nixdorf S; Hacker NF; Ward R; Heinzelmann-Schwarz V, 2014, 'Reversal of Forssman synthetase gene hypermethylation by 5-aza-2'-deoxycytidine in A2780 ovarian cancer cells', Geburtshilfe und Frauenheilkunde, vol. 74, http://dx.doi.org/10.1055/s-0034-1388354

Kwok CT; Vogelaar IP; Van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Rapkins RW; Ward RL; Chun N; Ford JM; Ladabaum U; McKinnon WC; Greenblatt MS; Hitchins MP, 2014, 'The MLH1 c.-27C>A and c.85G>T variants are linked to dominantly inherited MLH1 epimutation and are borne on a European ancestral haplotype', European Journal of Human Genetics, vol. 22, pp. 617 - 624, http://dx.doi.org/10.1038/ejhg.2013.200

Loke LPY; Ward RL; Garrad J; Faulkner KM; Kim A; King LH; Zheng A; Kelly A; Ryan P; Peterrnan D; Shingleton J; Rushton SA; Briscoe KP; Johnston A; Last A; Kerridge I; Aranda S; Currow D; Shapiro JD, 2014, 'EviQ cancer treatments online (www.eviQ.org.au): A widely used Australian resource.', JOURNAL OF CLINICAL ONCOLOGY, vol. 32, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.e17507

Patil V; Ward RL; Hesson LB, 2014, 'The evidence for functional non-CpG methylation in mammalian cells', Epigenetics, vol. 9, pp. 823 - 828, http://dx.doi.org/10.4161/epi.28741

Sloane MA; Hesson LB; Nunez AC; Thompson BA; Ward RL, 2014, 'Nucleosome positioning is unaltered at MLH1 splice site mutations in cells derived from Lynch syndrome patients', Clinical Epigenetics, vol. 6, pp. 32 - 32, http://dx.doi.org/10.1186/preaccept-1571082317134727

Sloane MA; Hesson LB; Nunez AC; Thompson BA; Ward RL, 2014, 'Nucleosome positioning is unaltered at MLH1 splice site mutations in cells derived from Lynch syndrome patients', Clinical Epigenetics, vol. 6, http://dx.doi.org/10.1186/s13148-014-0032-6

Sloane MA; Hesson LB; Ward RL, 2014, 'Epimutations and cancer susceptibility', eLS, vol. Published Online: 17 MAR 2014, pp. 1 - 10, http://dx.doi.org/10.1002/9780470015902.a0024615

Sloane MA; Wong JWH; Perera D; Nunez AC; Pimanda JE; Hawkins NJ; Sieber OM; Bourke MJ; Hesson LB; Ward RL, 2014, 'Epigenetic inactivation of the candidate tumor suppressor USP44 is a frequent and early event in colorectal neoplasia', Epigenetics, vol. 9, pp. 1092 - 1100, http://dx.doi.org/10.4161/epi.29222

Thompson BA; Spurdle AB; Plazzer JP; Greenblatt MS; Akagi K; Al-Mulla F; Bapat B; Bernstein I; Capellá G; Den Dunnen JT; Du Sart D; Fabre A; Farrell MP; Farrington SM; Frayling IM; Frebourg T; Goldgar DE; Heinen CD; Holinski-Feder E; Kohonen-Corish M; Robinson KL; Leung SY; Martins A; Moller P; Morak M; Nystrom M; Peltomaki P; Pineda M; Qi M; Ramesar R; Rasmussen LJ; Royer-Pokora B; Scott RJ; Sijmons R; Tavtigian SV; Tops CM; Weber T; Wijnen J; Woods MO; Macrae F; Genuardi M; Castillejo A; Sexton A; Chan AKW; Viel A; Blanco A; French A; Laner A; Wagner A; Van Den Ouweland A; Mensenkamp A; Payá A; Betz B; Redeker B; Smith B; Espenschied C; Cummings C; Engel C; Fornes C; Valenzuela C; Alenda C; Buchanan D; Barana D; Konstantinova D; Cairns D; Glaser E; Silva F; Lalloo F; Crucianelli F; Hogervorst F; Casey G; Tomlinson I; Blanco I; Villar IL; Garcia-Planells J; Bigler J; Shia J; Martinez-Lopez J; Gille JJP; Hopper J; Potter J; Soto JL; Kantelinen J; Ellis K; Mann K; Varesco L; Zhang L; Marchand LL; Marafie MJ; Nordling M; Tibiletti MG; Kahan MA; Ligtenberg M; Clendenning M; Jenkins M; Speevak M; Digweed M; Kloor M; Hitchins M; Myers M, 2014, 'Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database', Nature Genetics, vol. 46, pp. 107 - 115, http://dx.doi.org/10.1038/ng.2854

Vajdic CM; Er CC; Schaffer A; Dobbins T; Wyld L; Meagher NS; Barrett J; Ward RL; Pearson SA, 2014, 'An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data', Cancer Epidemiology, vol. 38, pp. 460 - 464, http://dx.doi.org/10.1016/j.canep.2014.05.004

Vajdic CM; Stavrou EP; Ward RL; Falster MO; Pearson SA, 2014, 'Minimal excess risk of cancer and reduced risk of death from cancer in Australian Department of Veterans' Affairs clients: A record linkage study', Australian and New Zealand Journal of Public Health, vol. 38, pp. 30 - 34, http://dx.doi.org/10.1111/1753-6405.12168

Ward RL, 2014, 'A decade of promises in personalized cancer medicine: Is the honeymoon over?', Medical Journal of Australia, vol. 200, pp. 132 - 133, http://dx.doi.org/10.5694/mja14.00018

Wyld L; Smith S; Hawkins NJ; Long J; Ward RL, 2014, 'Introducing research initiatives into healthcare: What do doctors think?', Biopreservation and Biobanking, vol. 12, pp. 91 - 98, http://dx.doi.org/10.1089/bio.2013.0069

Xu H; Yan Y; Deb S; Rangasamy D; Germann M; Malaterre J; Eder NC; Ward RL; Hawkins NJ; Tothill RW; Chen L; Mortensen NJ; Fox SB; McKay MJ; Ramsay RG, 2014, 'Cohesin Rad21 Mediates Loss of Heterozygosity and Is Upregulated via Wnt Promoting Transcriptional Dysregulation in Gastrointestinal Tumors', Cell Reports, vol. 9, pp. 1781 - 1797, http://dx.doi.org/10.1016/j.celrep.2014.10.059

Christie M; Jorissen RN; Mouradov D; Sakthianandeswaren A; Li S; Day F; Tsui C; Lipton L; Desai J; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruskiewicz A; Burgess A; Busam D; Zhao Q; Strausberg R; Simpson AJ; Tomlinson IP; Gibbs P; Sieber O, 2013, 'Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/â-catenin signalling thresholds for tumourigenesis', Oncogene, vol. 32, pp. 4675 - 4682, http://dx.doi.org/10.1038/onc.2012.486

Day FL; Jorissen RN; Lipton L; Mouradov D; Sakthianandeswaren A; Christie M; Li S; Tsui C; Tie J; Desai J; Xu ZZ; Molloy P; Whitehall V; Leggett BA; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Busam D; Zhao Q; Strausberg RL; Gibbs P; Sieber OM, 2013, 'PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in Colorectal cancer', Clinical Cancer Research, vol. 19, pp. 3285 - 3296, http://dx.doi.org/10.1158/1078-0432.CCR-12-3614

Fleming N; Jorissen RN; Mouradov D; Christie M; Sakthianandeswaren A; Palmieri M; Day F; Li S; Tsui C; Lipton L; Desai J; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruskiewicz A; Zhu HJ; Mariadason J; Burgess A; Busam D; Zhao Q; Strausberg R; Gibbs P; Sieber O, 2013, 'SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer', Cancer research, vol. 73, pp. 725 - 735, http://dx.doi.org/10.1158/0008-5472.CAN-12-2706

Ford CE; Jary E; Ma SSQ; Nixdorf S; Heinzelmann-Schwarz VA; Ward RL, 2013, 'The WNT gatekeeper SFRP4 modulates EMT, cell migration and downstream WNT signalling in serous ovarian cancer cells', PLoS ONE, vol. 8, pp. e54362, http://dx.doi.org/10.1371/journal.pone.0054362

Ford CE; Ma SSQ; Quadir A; Ward RL, 2013, 'The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis', International Journal of Cancer, vol. 133, pp. 779 - 787, http://dx.doi.org/10.1002/ijc.27984

Hesson LB; Patil V; Sloane MA; Nunez AC; Liu J; Pimanda JE; Ward RL, 2013, 'Reassembly of Nucleosomes at the MLH1 Promoter Initiates Resilencing Following Decitabine Exposure', PLoS Genetics, vol. 9, http://dx.doi.org/10.1371/journal.pgen.1003636

Langton JM; Pesa N; Rushton S; Ward RL; Pearson S, 2013, 'Uptake of a web-based oncology protocol system: How do cancer clinicians use eviQ Cancer Treatments Online?', BMC Cancer, vol. 13, pp. 112, http://dx.doi.org/10.1186/1471-2407-13-112

Liu J; Hesson LB; Ward RL, 2013, 'Liquid chromatography tandem mass spectrometry for the measurement of global DNA methylation and hydroxymethylation', Journal of Proteomics & Bioinformatics, vol. 01, http://dx.doi.org/10.4172/jpb.S2-005

Loh YN; Hedditch E; Baker L; Jary E; Ward RL; Ford CE, 2013, 'The Wnt signalling pathway is upregulated in acquired Tamoxifen resistant breast cancer.', BMC Cancer, vol. 13, pp. 174, http://dx.doi.org/10.1186/1471-2407-13-174

Lu CY; Srasuebkul P; Drew A; Ward RL; Pearson S, 2013, 'Trastuzumab therapy in Australia: Which patients with HER2+ metastatic breast cancer are assessed for cardiac function?', Breast, vol. 22, pp. 482 - 487, http://dx.doi.org/10.1016/j.breast.2013.04.011

Mak G; Ward R; Shehabi Y; Venkateswaran R; Chin M, 2013, 'Use of neostigmine in capecitabine-induced paralytic ileus', Tumori Journal, vol. 99, pp. e225 - e228, http://dx.doi.org/10.1177/030089161309900518

Mak G; Ward R; Shehabi Y; Venkateswaran R; Chin M, 2013, 'Use of neostigmine in capecitabine-induced paralytic ileus', Tumori, vol. 99, http://dx.doi.org/10.1700/1377.15320

Metz AJ; Bourke MJ; Moss A; Dower A; Zarzour P; Hawkins NJ; Ward RL; Hesson L, 2013, 'A correlation of the endoscopic characteristics of colonic laterally spreading tumours (LSTs) with genetic alterations', European Journal of Gastroenterology and Hepatology, vol. 25, pp. 319 - 326, http://dx.doi.org/10.1097/MEG.0b013e32835b57e7

Mouradov D; Domingo E; Gibbs P; Jorissen RN; Li S; Soo PY; Lipton L; Desai J; Danielsen HE; Oukrif D; Novelli M; Yau C; Holmes CC; Jones IT; McLaughlin S; Molloy P; Hawkins NJ; Ward R; Midgely R; Kerr D; Tomlinson IP; Sieber OM, 2013, 'Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations', American Journal of Gastroenterology, vol. 108, pp. 1785 - 1793, http://dx.doi.org/10.1038/ajg.2013.292

Nanda KS; Burgess NG; Williams SJ; Singh R; Hourigan LF; Zanati SA; Brown GJ; Ward RL; Sonson R; Acharya P; Byth K; Bourke MJ, 2013, 'Su1036 Phenotypic Expression of Large (≥ 20mm) Sessile Serrated Adenomas of the Colon As a Predictor of High Grade Dysplasia or Colorectal Cancer in a Multicenter Prospective Cohort', Gastroenterology, vol. 144, pp. S - 381, http://dx.doi.org/10.1016/s0016-5085(13)61404-3

Ward RL, 2013, 'Population-Based Molecular Screening for Lynch Syndrome: Implications for Personalized Medicine (vol 31, pg 2554, 2013)', JOURNAL OF CLINICAL ONCOLOGY, vol. 31, pp. 4167 - 4167, http://dx.doi.org/10.1200/JCO.2013.53.9056

Ward RL; Dobbins T; Lindor NM; Rapkins R; Hitchins MP, 2013, 'Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family registry', Genetics in Medicine, vol. 15, pp. 25 - 35, http://dx.doi.org/10.1038/gim.2012.91

Ward RL; Hicks S; Hawkins NJ, 2013, 'Population based molecular screening for Lynch Syndrome – implications for personalized medicine', Journal of Clinical Oncology, vol. 31, pp. 2554 - 2562, http://dx.doi.org/10.1200/JCO.2012.46.8454

Webster LR; Provan PJ; Graham DJ; Byth K; Walker RL; Davis S; Salisbury EL; Morey AL; Ward RL; Hawkins NJ; Clarke CL; Meltzer PS; Balleine RL, 2013, 'Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33', Pathology, vol. 45, pp. 629 - 636, http://dx.doi.org/10.1097/PAT.0000000000000004

Zarzour P; Hesson LB; Ward RL, 2013, 'Establishing the clinical utility of epigenetic markers in cancer: Many challenges ahead', Epigenomics, vol. 5, pp. 513 - 523, http://dx.doi.org/10.2217/epi.13.53

Campone M; Bondarenko I; Brincat S; Hotko Y; Munster PN; Chmielowska E; Fumoleau P; Ward RL; Bardy-Bouxin N; Leip E; Turnbull K; Zacharchuk C; Epstein RJ, 2012, 'Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy', Annals of Oncology, vol. 23, pp. 610 - 617, http://dx.doi.org/10.1093/annonc/mdr261

Ford CE; Jary E; Ma S; Nixdorf S; Heinzelmann-Schwarz V; Ward RL, 2012, 'SFRP4 modulates EMT, cell migration and downstream Wnt signalling in epithelial ovarian cancer.', CANCER RESEARCH, vol. 72, http://dx.doi.org/10.1158/1538-7445.AM2012-333

Hains I; Ward RL; Pearson S, 2012, 'Implementing a web-based oncology protocol system in Australia: Evaluation of the first three years of operation', Internal Medicine Journal, vol. 42, pp. 57 - 64, http://dx.doi.org/10.1111/j.1445-5994.2010.02284.x

Haywood P; de Raad J; van Gool K; Haas M; Gallego G; Pearson S; Faedo M; Ward RL, 2012, 'Chemotherapy administration: modelling the costs of alternative protocols', Pharmacoeconomics, vol. 30, pp. 1173 - 1186, http://dx.doi.org/10.2165/11597280-000000000-00000

Hesson L; Packham D; Pontzer E; Funchain P; Eng C; Ward RL, 2012, 'A reinvestigation of somatic hypermethylation at the PTEN CpG island in cancer cell lines', Biological Procedures Online, vol. 14, pp. 1 - 8, http://dx.doi.org/10.1186/1480-9222-14-5

Hesson LB; Wong JWH; Sloane MA; Pimanda JE; Bourke MJ; Hawkins NJ; Ward RL, 2012, 'Nucleosome occupancy at unmethylated promoter CpG islands represents a novel mechanism of epigenetic gene silencing in cancer', CANCER RESEARCH, vol. 72, http://dx.doi.org/10.1158/1538-7445.AM2012-990

Liu J; Hesson L; Meagher AP; Bourke MJ; Hawkins NJ; Rand KN; Molloy PL; Pimanda JE; Ward RL, 2012, 'Relative distribution of folate species is associated with global DNA methylation in human colorectal mucosa', CANCER PREVENTION RESEARCH, vol. 5, pp. 921 - 929, http://dx.doi.org/10.1158/1940-6207.CAPR-11-0577

Lu CY; Srasuebkul P; Drew A; Ward RL; Pearson S, 2012, 'Positive spillover effects of prescribing requirements: Increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer', Internal Medicine Journal, vol. 42, pp. 1229 - 1235, http://dx.doi.org/10.1111/j.1445-5994.2011.02604.x

Sigglekow ND; Pangon L; Brummer T; Molloy M; Hawkins NJ; Ward RL; Musgrove EA; Kohonen-Corish M, 2012, 'Mutated in Colorectal Cancer Protein Modulates the NFKB Pathway', Anticancer Research, vol. 32, pp. 73 - 80, http://www.ncbi.nlm.nih.gov/pubmed/22213290

Srasuebkul P; Dobbins TA; Ward RL; Haas M; Van gool K; Pearson S, 2012, 'Validation of a proxy for estrogen receptor status in breast cancer patients using dispensing data', Pharmacoepidemiology and Drug Safety, vol. 10, http://dx.doi.org/10.1111/ajco.12015

Stavrou EP; Ward RL; Pearson S, 2012, 'Oesophagectomy rates and post-resection outcomes in patients with cancer of the oesophagus and gastro-oesophageal junction: A population-based study using linked health administrative linked data', BMC Health Services Research, vol. 12, pp. 384, http://dx.doi.org/10.1186/1472-6963-12-384

Vajdic CM; Meagher N; Hicks S; Faedo M; Ward RL; Pearson S, 2012, 'Governance approval for multisite, non-interventional research: What can Harmonisation of Multi-Centre Ethical Review learn from the New South Wales experience?', Internal Medicine Journal, vol. 42, pp. 127 - 131, http://dx.doi.org/10.1111/j.1445-5994.2011.02431.x

Adelstein BA; Dobbins TA; Harris CA; Marschner IC; Ward RL, 2011, 'A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancer', European Journal of Cancer, vol. 47, pp. 1343 - 1354, http://dx.doi.org/10.1016/j.ejca.2011.03.031

Arkenau H; Nordman-Nowakowski II; Dobbins TA; Ward RL, 2011, 'Reporting time to event endpoints and response rates in four decades of randomized controlled trials in advanced colorectal cancer', Cancer, vol. 117, pp. 832 - 840, http://dx.doi.org/10.1002/cncr.25636

Daly J; Davidson PM; Duffield C; Campbell TJ; Ward RL, 2011, 'Interdisciplinary, cross-institutional collaborations: the Academic Health Sciences Centre as a key to addressing complex health problems and advancing research-based health care', Collegian, vol. 18, pp. 1 - 2, http://dx.doi.org/10.1016/j.colegn.2011.01.003

Goel A; Nguyen T; Leung H; Nagasaka T; Rhees J; Hotchkiss E; Arnold M; Banerji P; Koi M; Kwok C; Packham D; Lipton L; Boland CR; Ward RL; Hitchins MP, 2011, 'De novo constitutional MLH1 epimutations confer early-onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one', International Journal of Cancer, vol. 128, pp. 869 - 878, http://dx.doi.org/10.1002/ijc.25422

Harris CA; Ward RL; Dobbins TA; Drew A; Pearson S, 2011, 'The efficacy of HER2-targeted agents in metastatic breast cancer: A meta-analysis', Annals of Oncology, vol. 22, pp. 1308 - 1317, http://dx.doi.org/10.1093/annonc/mdq593

Hesson LB; Patil V; Sloane M; Ward RL, 2011, 'Investigation of the molecular events associated with gene resilencing following withdrawal of epigenetic therapies', CANCER RESEARCH, vol. 71, http://dx.doi.org/10.1158/1538-7445.AM2011-2000

Hicks S; Ward RL; Hawkins NJ, 2011, 'Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma: letter to the editor', Pathology, vol. 43, pp. 84 - 85, http://dx.doi.org/10.1097/PAT.0b013e3283410b26

Hitchins MP; Rapkins R; Kwok C; Srivastava S; Wong JJ; Khachigian LM; Polly P; Goldblatt J; Ward RL, 2011, 'Dominantly Inherited Constitutional Epigenetic Silencing ofMLH1inaCancer-Affected Family IsLinked to a Single Nucleotide Variant within the 5'UTR', Cancer Cell, vol. 20, pp. 200 - 213, http://dx.doi.org/10.1016/J.ccr/2011.07.003

Langton JM; Drew A; Mellish L; Olivier J; Ward RL; Pearson S, 2011, 'The quality of web-based oncology guidelines and protocols: how do international sites stack up?', British Journal of Cancer, vol. 105, pp. 1166 - 1172, http://dx.doi.org/10.1038/bjc.2011.378

Liu J; Pickford R; Meagher AP; Ward RL, 2011, 'Quantitative analysis of tissue folate using ultra-high performance liquid chromatography tandem mass spectrometry', Analytical Biochemistry, vol. 411, pp. 210 - 217, http://dx.doi.org/10.1016/j.ab.2010.12.033

Liu JJ; Hesson LB; Rand KN; Molloy PL; Pimanda J; Ward RL, 2011, 'Analysis of global and repeat sequence DNA methylation in the blood and normal colonic mucosa of colorectal cancer patients, healthy individuals and patients with folate deficiency', CANCER RESEARCH, vol. 71, http://dx.doi.org/10.1158/1538-7445.AM2011-91

Wong JJ; Hawkins NJ; Ward RL; Hitchins MP, 2011, 'Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer.', Modern Pathology, vol. 24, pp. 396 - 411, http://dx.doi.org/10.1038/modpathol.2010.212

Arkenau H; Ringland C; Ward RL; O''Connell DL, 2010, 'Second primary colorectal cancers (SPCRCs): experiences from a large Australian Cancer Registry', Annals of Oncology, vol. 21, pp. 92 - 97, http://dx.doi.org/10.1093/annonc/mdp288

De raad J; van Gool K; Haas M; Haywood P; Faedo M; Gallego G; Pearson S; Ward RL, 2010, 'Nursing takes time: workload associated with administering cancer protocols', Clinical Journal of Oncology Nursing, vol. 14, pp. 735 - 741, http://dx.doi.org/10.1188/10.CJON.735-741

Hesson L; Hitchins MP; Ward RL, 2010, 'Epimutations and cancer predisposition: importance and mechanisms', Current Opinion in Genetics and Development, vol. 20, pp. 1 - 9, http://dx.doi.org/10.1016/j.gde.2010.02.005

Hill VK; Hesson L; Dansranjavin T; Dallol A; Bieche I; Vacher S; Tommasi S; Dobbins TA; Gentle D; Euhus D; Dammann R; Ward RL; Minna JD; Maher ER; Pfeifer G; Latif F, 2010, 'Identification of 5 novel genes methylated in breast and other epithelial cancers', Molecular Cancer Research, vol. 9, pp. 51 - 66, http://dx.doi.org/10.1186/1476-4598-9-51

Hwang HS; Elbaz D; Magdis G; Daddi E; Symeonidis M; Altieri B; Amblard A; Andreani P; Arumugam V; Auld R; Aussel H; Babbedge T; Berta S; Blain A; Bock J; Bongiovanni A; Boselli A; Buat V; Burgarella D; Castro-Rodríguez N; Cava A; Cepa J; Chanial P; Chapin E; Chary RR; Cimatti A; Clements DLZ; Conley A; Conversi L; Cooray A; Dannerbauer H; Dickinson M; Dominguez H; Dowell CD; Dunlop JS; Dwek E; Eales S; Farrah D; Schreiber NF; Fox M; Franceschini A; Gear W; Genzel R; Glenn J; Griffin M; Gruppioni C; Halpern M; Hatziminaoglou E; Ibar E; Isaak K; Ivison RJ; Jeong WS; Lagache G; Le Borgne D; Le Floc'h E; Lee HM; Lee JC; Lee MG; Levenson L; Lu N; Lutz D; Madden S; Maffei B; Magnelli B; Mainetti G; Maiolino R; Marchetti L; Mortier AMJ; Nguyen HT; Nordon R; O'Halloran B; Okumura K; Oliver SJ; Omont A; Page MJ; Panuzzo P; Papageorgiou A; Pearson CP; Pérez-Fournon I; García AMP; Poglitsch A; Pohlen M; Popesso P; Pozzi F; Rawlings JI; Rigopoulou D; Riguccini L; Rizzo D; Rodighiero G; Roseboom IG; Rowan-Robinson M; Saintonge A; Portal MS; Santini P; Sauvage M; Schulz B; Scott D; Seymour N; Shao L; Shupe DL, 2010, 'Evolution of dust temperature of galaxies through cosmic time as seen by Herschel', Monthly Notices of the Royal Astronomical Society, vol. 409, pp. 75 - 82, http://dx.doi.org/10.1111/j.1365-2966.2010.17645.x

Ivison RJ; Magnelli B; Ibar E; Andreani P; Elbaz D; Altieri B; Amblard A; Arumugam V; Auld R; Aussel H; Babbedge T; Berta S; Blain A; Bock J; Bongiovanni A; Boselli A; Buat V; Burgarella D; Castro-Rodríguez N; Cava A; Cepa J; Chanial P; Cimatti A; Cirasuolo M; Clements DL; Conley A; Conversi L; Cooray A; Daddi E; Dominguez H; Dowell CD; Dwek E; Eales S; Farrah D; FörsterSchreiber N; Fox M; Franceschini A; Gear W; Genzel R; Glenn J; Griffin M; Gruppioni C; Halpern M; Hatziminaoglou E; Isaak K; Lagache G; Levenson L; Lu N; Lutz D; Madden S; Maffei B; Magdis G; Mainetti G; Maiolino R; Marchetti L; Morrison GE; Mortier AMJ; Nguyen HT; Nordon R; O'Halloran B; Oliver SJ; Omont A; Owen FN; Page MJ; Panuzzo P; Papageorgiou A; Pearson CP; Pérez-Fournon I; García AMP; Poglitsch A; Pohlen M; Popesso P; Pozzi F; Rawlings JI; Raymond G; Rigopoulou D; Riguccini L; Rizzo D; Rodighiero G; Roseboom IG; Rowan-Robinson M; Saintonge A; SanchezPorta M; Santini P; Schulz B; Scott D; Seymour N; Shao L; Shupe DL; Smith AJ; Stevens JA; Sturm E; Symeonidis M; Tacconi L; Trichas M; Tugwell KE; Vaccari M; Valtchanov I; Vieira J; Vigroux L, 2010, 'The far-infrared/radio correlation as probed by Herschel', Astronomy and Astrophysics, vol. 518, http://dx.doi.org/10.1051/0004-6361/201014552

Kwok CK; Ward RL; Hawkins NJ; Hitchins MP, 2010, 'Detection of allelic imbalance in MLH1 expression by pyrosequencing serves as a tool for the identification of germline defects in Lynch syndrome', Familial Cancer, vol. 9, pp. 345 - 356, http://dx.doi.org/10.1007/s10689-009-9314-0

Liu J; Ward RL, 2010, 'Folate and one-carbon metabolism and its impact on aberrant DNA methylation in cancer', Advances in Genetics, vol. 71, pp. 80 - 121, http://dx.doi.org/10.1016/B978-0-12-380864-6.00004-3

Pearson S; Chin M; Faedo M; Ward RL, 2010, 'Rationale for treatment durations of targeted cancer agents', Lancet Oncology, vol. 11, pp. 1113 - 1115, http://dx.doi.org/10.1016/S1470-2045(10

Tebbutt NC; Wilson K; Gebski VJ; Cummins MM; Zannino D; Van Hazel GA; Robinson B; Broad A; Ganju V; Ackland SP; Forgeson G; Cunningham D; Saunders MP; Stockler MR; Chua Y; Zalcberg JR; Simes RJ; Price TJ; Coates A; O'Connell D; Brown C; Hague W; France A; Hicks S; James R; Masson R; O'Connell R; Pike R; Shoulder J; Stevens L; Tunney V; Vachan B; Wong N; Ackland S; Moylan E; Strickland A; Abdi E; Ransom D; Lowenthal R; Marx G; Nayagam SS; Shannon J; Goldstein D; Karapetis C; Blum R; Eek R; Ward R; Pavlakis N; Wilcken N; Burns I; Wyld D; Underhill C; Claringbold P; Liauw W; Clingan P; Jefford M; Horvath L; McKendrick J; Chong G; Boyce A; Cassidy J; Kirsten F; Clarke S; Guo Y; Innes-Rowe J; Smith A; Williams J; Tournier E; Maliepaard S; Vitullo E; Humm G; Nguyen V; Midolo P; Chorlton C; McDonald L; Oliver L; Sjursen AM; Inglis C; Marafioti T; McCourt J; Howard J; Richards A; Provis A; Rundle A; Whatman A; Emmett L; Raymond B; Byrne S; Withers E; Campbell J; Hodgkins C; Szwajcer M; Parker S; Welby S; Page F; Corker M; Wykes R; Goss C; Whitney S; Oates J, 2010, 'Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study', Journal of Clinical Oncology, vol. 28, pp. 3191 - 3198, http://dx.doi.org/10.1200/JCO.2009.27.7723

Trainer A; Lewis C; Tucker K; Meiser B; Friedlander M; Ward RL, 2010, 'The role of BRCA mutation testing in determining breast cancer therapy', Nature Reviews Clinical Oncology, vol. 7, pp. 708 - 717, http://dx.doi.org/10.1038/nrclinonc.2010.175

Trainer A; Ward RL, 2010, 'How to treat familial cancer', Australian Doctor, vol. 6, pp. 29 - 36

Carr N; Mahajan H; Tan K; Hawkins NJ; Ward RL, 2009, 'Serrated and non-serrated polyps of the colorectum: Their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma', Journal of Clinical Pathology, vol. 62, pp. 516 - 518, http://dx.doi.org/10.1136/jcp.2008.061960

Carr NJ; Tan KL; Mahajan H; Hawkins NJ; Ward RL; Nguyen Q, 2009, 'Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma', Pathology, vol. 41, pp. 66 - 66, http://dx.doi.org/10.1097/01268031-200941001-00151

Cooper W; Hesson L; Matallanas D; Dallol A; Von Kriegsheim A; Ward RL; Kolch W; Latif F, 2009, 'RASSF2 associates with and stabilizes the proapoptotic kinase MST2', Oncogene, vol. 28, pp. 2988 - 2998, http://dx.doi.org/10.1038/onc.2009.152

Hains I; Fuller J; Ward RL; Pearson S, 2009, 'Standardizing care in medical oncology: Are web-based systems the answer?', Cancer, vol. 115, pp. 5579 - 5588, http://dx.doi.org/10.1002/cncr.24600

Hawkins NJ; Lee J; Wong JJ; Kwok C; Ward RL; Hitchins MP, 2009, 'MGMT methylation is associated primarily with the germline C > T SNP (rs16906252) in colorectal cancer and normal colonic mucosa', Modern Pathology, vol. 22, pp. 1588 - 1599, http://dx.doi.org/10.1038/modpathol.2009.130

Hitchins MP; Ward RL, 2009, 'Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer', Journal of Medical Genetics, Electronic, vol. 46, pp. 793 - 802, http://dx.doi.org/10.1136/jmg.2009.068122

Hitchins MP; Ward RL, 2009, 'Favoritism in DNA Methylation', CANCER PREVENTION RESEARCH, vol. 2, pp. 847 - 849, http://dx.doi.org/10.1158/1940-6207.CAPR-09-0178

Neumann H; Erlic Z; Boedeker C; Rybicki L; Robledo M; Hermsen M; Schiavi F; Falcioni M; Kwok P; Bauters C; Lampe K; Fischer M; Edelman E; Benn DE; Robinson BG; Wiegand S; Rasp G; Stuck B; hoffmann M; Sullivan MR; Sevilla M; Weiss M; Peczkowska M; Kubaszek A; Pigny P; Ward RL; Learoyd D; Croxson MS; Zabolotny D; Yaremchuk S; Draf W; Muresan M; Lorenz R; Knipping S; Strohm M; Dyckhoff G; Matthias C; Reisch N; Preuss S; Esser D; Walter M; Kaftan H; Stoever T; Fottner C; Gorgulla H; Malekpour M; Zarandy M; Schipper J; Brase C; Glien A; Kuehnemund M; Koscielny S; Schwerdtfeger P; Valimaki M; Szyfter W; Finckh U; Zerres K; Cascon A; Opocher G; Ridder G; Januszewicz A; Suarez C; Eng C, 2009, 'Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out', Cancer research, vol. 69, pp. 3650 - 3656, http://dx.doi.org/10.1158/0008-5472.CAN-08-4057

Packham D; Ward R; Lin VA; Hawkins NJ; Hitchins MP, 2009, 'Implementation of novel pyrosequencing assays to screen for common mutations of BRAF and KRAS in a cohort of sporadic colorectal cancers', Diagnostic Molecular Pathology, vol. 18, pp. 62 - 71, http://dx.doi.org/10.1097/PDM.0b013e318182af52

Samuel M; Suzuki H; Buchert M; Putoczki T; Tebbutt N; Lundgren-May T; Christou A; Inglese M; Toyota M; Heath J; Ward RL; Waring P; Ernst M, 2009, 'Elevated Dnmt3a Activity Promotes Polyposis in ApcMin Mice by Relaxing Extracellular Restraints on Wnt Signaling', Gastroenterology, vol. 137, pp. 902 - 913.11, http://dx.doi.org/10.1053/j.gastro.2009.05.042

Hitchins MP; Ward RL, 2008, 'MLH1 germ-line epimutations: Is there strong evidence of its inheritance?', BMC Gastroenterology, vol. 134, pp. 359 - 360, http://dx.doi.org/10.1053/j.gastro.2007.11.054

Hitchins MP; Ward RL, 2008, 'Reply', Gastroenterology, vol. 134, pp. 359 - 360, http://dx.doi.org/10.1053/j.gastro.2007.11.054

Segditsas S; Sieber O; Rowan A; Setien F; Neale K; Phillips R; Ward RL; Esteller M; Tomlinson IP, 2008, 'Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations', Experimental and Molecular Pathology, vol. 85, pp. 201 - 206, http://dx.doi.org/10.1016/j.yexmp.2008.09.006

Wakefield CE; Meiser B; Homewood J; Peate ML; Taylor A; Lobb EA; Kirk J; Young M; Williams R; Dudding T; Tucker K, 2008, 'A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk', Breast Cancer Research and Treatment, vol. 107, pp. 289 - 301, http://dx.doi.org/10.1007/s10549-007-9539-2

Wakefield CE; Meiser B; Homewood J; Taylor A; Gleeson MA; Williams R; Tucker K; Ward RL, 2008, 'A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling', Psycho - Oncology, vol. 17, pp. 844 - 854, http://dx.doi.org/10.1002/pon.1353

Wakefield CE; Meiser B; Homewood J; Ward RL; O Donnell S; Kirk J, 2008, 'Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk', Cancer, vol. 113, pp. 956 - 965, http://dx.doi.org/10.1002/cncr.23681

Weber MF; Banks E; Ward RL; Sitas F, 2008, 'Population characteristics related to colorectal cancer testing in NSW, Australia: Results from the 45 and up study cohort', Journal of Medical Screening, vol. 15, pp. 137 - 142, http://dx.doi.org/10.1258/jms.2008.008050

Webster L; Lee S; Ringland C; Morey AL; Hanby A; Morgan GJ; Byth K; Mote P; Provan P; Ellis I; R A; Lamoury GM; Ravdin P; Clarke CL; Ward RL; Balleine R; Hawkins NJ, 2008, 'Poor-Prognosis Estrogen Receptor - Positive Breast Cancer Identified by Histopathologic Subclassification', Clinical Cancer Research, vol. 14, pp. 6625 - 6633, http://dx.doi.org/10.1158/1078-0432.CCR-08-0701

Easton DF; Pooley KA; Dunning AM; Pharoah PDP; Thompson D; Ballinger DG; Struewing JP; Morrison J; Field H; Luben R; Wareham N; Ahmed S; Healey CS; Bowman R; Meyer KB; Haiman CA; Kolonel LK; Henderson BE; Le Marchand L; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Eccles D; Evans DG; Peto J; Fletcher O; Johnson N; Seal S; Stratton MR; Rahman N; Chenevix-Trench G; Bojesen SE; Nordestgaard BG; Axelsson CK; Garcia-Closas M; Brinton L; Chanock S; Lissowska J; Peplonska B; Nevanlinna H; Fagerholm R; Eerola H; Kang D; Yoo KY; Noh DY; Ahn SH; Hunter DJ; Hankinson SE; Cox DG; Hall P; Wedren S; Liu J; Low YL; Bogdanova N; Schürmann P; Dörk T; Tollenaar RAEM; Jacobi CE; Devilee P; Klijn JGM; Sigurdson AJ; Doody MM; Alexander BH; Zhang J; Cox A; Brock IW; MacPherson G; Reed MWR; Couch FJ; Goode EL; Olson JE; Meijers-Heijboer H; Van Den Ouweland A; Uitterlinden A; Rivadeneira F; Milne RL; Ribas G; Gonzalez-Neira A; Benitez J; Hopper JL; McCredie M; Southey M; Giles G; Schroen C; Justenhoven C; Brauch H; Hamann U; Ko YD; Spurdle AB; Beesley J; Chen X; Mannermaa A; Kosma VM; Kataja V; Hartikainen J; Day NE, 2007, 'Genome-wide association study identifies novel breast cancer susceptibility loci', Nature, vol. 447, pp. 1087 - 1093, http://dx.doi.org/10.1038/nature05887

Hettiaratchi A; Hawkins NJ; McKenzie GL; Ward RL; Hunt JE; Wakefield D; Di Girolamo N, 2007, 'The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer', British Journal of Cancer, vol. 96, pp. 783 - 792, http://dx.doi.org/10.1038/sj.bjc.6603630

Hitchins MP; Ap Lin V; Buckle AD; Cheong KF; Halani N; Ku S; Kwok C; Packham D; Suter CM; Meagher AP; Stirzaker C; Clark SJ; Hawkins NJ; Ward RL, 2007, 'Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer', Cancer research, vol. 67, pp. 9107 - 9116, http://dx.doi.org/10.1158/0008-5472.CAN-07-0869

Hitchins MP; Ward RL, 2007, 'Addendum: Germline epimutation of MLH1 in individuals with multiple cancers', Nature Genetics, vol. 39, pp. 1414 - 1414, http://dx.doi.org/10.1038/ng1107-1414

Hitchins MP; Ward RL, 2007, 'Erasure of MLH1 methylation in spermatozoa implications for epigenetic inheritance', Nature Genetics, vol. 39, pp. 1289 - 1289, http://dx.doi.org/10.1038/ng1107-1289

Hitchins MP; Wong JJ; Suthers GK; Suter CM; Martin DI; Hawkins NJ; Ward RL, 2007, 'Inheritance of a cancer-associated MLH1 germ-line epimutation', New England Journal of Medicine, vol. 356, pp. 697 - 705, http://dx.doi.org/10.1056/NEJMoa064522

Ioannidis JP; Ahmed T; Awashi S; Clarfield M; Clark J; Dandona L; Howe A; Lozano JM; Li Y; Madani H; Marusic A; Mohammed I; Purcell GG; Rhoads M; Sliwa-Hahnle K; Straus S; Tan-Torres Edejer T; Tugwell P; Ward RL; Wilkes MS; Smith R, 2007, 'Open letter to the leader of academic medicine', British Medical Journal: International, vol. 334 (7586), pp. 191 - 193

More H; Humar B; Ward RL; Christian A; Lintott C; Graziano F; Ruzzo A; Acosta E; Boman B; Harlan M; Ferreira P; Seruca R; Suriano G; Guilford P, 2007, 'Identification of Seven Novel Germline Mutation sin the Human E-Cadherin (CDH1) Gene', Human Mutation, vol. 28, pp. 203 - 203, http://dx.doi.org/10.1002/humu.9473

Pearson S; Ringland C; Ward RL, 2007, 'Trastuzumab and metastatic breast cancer: Trastuzumab use in Australia - Monitoring the effect of an expensive medicine access program', Journal of Clinical Oncology, vol. 25, pp. 3688 - 3693, http://dx.doi.org/10.1200/JCO.2007.11.2516

Pearson S; Ringland C; Ward RL, 2007, 'Use of trastuzumab for metastatic breast cancer in Australia: Interpreting findings from a cohort of 1,469 women on a national access program versus 41 women treated by two medical oncologists', Journal of Clinical Oncology, vol. 25, pp. 5663 - 5664, http://dx.doi.org/10.1200/JCO.2007.14.3099

Wong JJ; Hawkins NJ; Ward RL, 2007, 'Colorectal cancer: a model for epigenetic tumorigenesis', Gut, vol. 56, pp. 140 - 148, http://dx.doi.org/10.1136/gut.2005.088799

van Gool K; Gallego G; Haas M; Viney R; Hall J; Ward RL, 2007, 'Economic evidence at the local level - Options for making it more useful', Pharmacoeconomics, vol. 25, pp. 1055 - 1062, http://dx.doi.org/10.2165/00019053-200725120-00006

Brown DA; Stephan C; Ward RL; Law MG; Hunter M; Bauskin AR; Amin J; Jung K; Diamandis E; Hampton GM; Russell PJ; Giles GG; Breit SN, 2006, 'Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis', Clinical Cancer Research, vol. 12, pp. 89 - 96, http://dx.doi.org/10.1158/1078-0432.CCR-05-1331

Colebatch A; Hitchins MP; Williams R; Meagher AP; Hawkins NJ; Ward RL, 2006, 'The role of MYH and microsatellite instability in the development of sporadic colorectal cancer', British Journal of Cancer, vol. 95, pp. 1239 - 1243, http://dx.doi.org/10.1038/sj.bjc.6603421

Gazarian M; Kelly M; McPhee J; Graudins LV; Ward RL; Campbell TJ, 2006, 'Off label use of medicines: consensus recommendations for evaluating appropriateness', Medical Journal of Australia, vol. 185, pp. 544 - 548

Heinzelmann VA; Scolyer RA; Scurry JP; Smith AN; Scolyer RA; Gardiner-Garden M; Biankin AV; Baron-Hay S; Scott C; Ward R; Fink D; Hacker NF; Sutherland RL; O Brien P, 2006, 'Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries', Journal of Clinical Pathology, vol. 60, pp. 1 - 12, http://dx.doi.org/10.1136/jcp.2005.034223

Hitchins MP; Suter CM; Wong J; Cheong K; Hawkins NJ; Leggett B; Scott R; Spigelman AD; Tomlinson IP; Martin DI; Ward RL, 2006, 'Germline epimutations of APC are not associated with inherited colorectal polyposis', Gut, vol. 55, pp. 586 - 587, http://dx.doi.org/10.1136/gut.2005.087486

Johnson K; Ringland C; Stokes B; Anthony D; Freemantle N; Irs A; Hill S; Ward RL, 2006, 'Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis', Lancet Oncology, vol. 7, pp. 741 - 746, http://dx.doi.org/10.1016/S1470-2045(06)70800-2

Kang HH; Williams RB; Leary JA; Ringland C; Kirk J; Ward RL, 2006, 'Evaluation of models to predict BRCA germline mutations', British Journal of Cancer, vol. 95, pp. 914 - 920, http://dx.doi.org/10.1038/sj.bjc.6603358

Tan E; Stark HL; Lowinger J; Ringland C; Ward RL; Pearson S, 2006, 'Information sources used by New South Wales cancer clinicians: a qualitative study', Internal Medicine Journal, vol. 36, pp. 711 - 717, http://dx.doi.org/10.1111/j.1445-5994.2006.01171.x

Ward RL; Turner J; Hawkins NJ, 2006, 'Re: Ward et al. Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified. J Pathol 2005;207 : 377-384 - Authors` reply', Journal of Pathology, vol. 208, pp. 592 - 592, http://dx.doi.org/10.1002/path.1932

Awasthi S; Beardmore J; Clark J; Hadridge P; Madani H; Marusic A; Purcell G; Rhoads M; Sliwa-Hähnle K; Smith R; Edejer TTT; Tugwell P; Underwood T; Ward R; International CTRAM, 2005, 'Five futures for academic medicine.', PLoS medicine, vol. 2

Awasthi S; Beardmore J; Clark J; Hadridge P; Madani H; Marusic A; Purcell GG; Rhoads M; Sliwa-Hahnle K; Smith RW; Edejer T; Tugwell P; Underwood T; Ward RL, 2005, 'Five futures for academic medicine', PLOS Medicine, vol. 2, pp. 606 - 613, http://dx.doi.org/10.1371/journal.pmed.0020207

Clark J, 2005, 'Five futures for academic medicine: The ICRAM scenarios', British Medical Journal, vol. 331, pp. 101 - 104, http://dx.doi.org/10.1136/bmj.331.7508.101

Hall WD; Ward RL; Liauw WS; Brien JE; Lu CY, 2005, 'Tailoring access to high cost, genetically targeted drugs', Medical Journal of Australia, vol. 182, pp. 607 - 608

Hitchins MP; Williams RA; Cheong KF; Halani N; Lin V; Packham D; Ku S; Buckle AD; Hawkins NJ; Burn J, 2005, 'MLH1 Germline Epimutations as a Factor in Hereditary Nonpolyposis Colorectal Cancer', Gastroenterology, vol. 129, pp. 1392 - 1399, http://dx.doi.org/10.1053/j.gastro.2005.09.003

Johnson K; Stokes B; Anthony D; Ward R; Freemantle N; Hill S, 2005, 'Modeling oncology surrogate markers', Journal of Clinical Oncology, vol. 23, pp. 9639 - 9639, http://dx.doi.org/10.1200/jco.2005.23.16_suppl.9639

Johnson K; Stokes B; Anthony D; Ward RL; Freemantle N; Hill S, 2005, 'Modeling oncology surrogate markers', Journal of Clinical Oncology, vol. 23, pp. 871S - 871S, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230326605521&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Kairupan CF; Meldrum C; Crooks R; Milward EA; Spigelman AD; Burgess B; Groombridge C; Kirk J; Tucker K; Ward RL; Williams R; Scott R, 2005, 'Mutation analysis of the MYH gene in an Australian series of colorectal polyposis patients with or without germline APC mutations', International Journal of Cancer, vol. 116, pp. 73 - 77, http://dx.doi.org/10.1002/ijc.20983

Liauw W; Segelov E; Lih A; Links M; Dunleavy R; Ward R, 2005, 'Outcomes and utilization patterns of intravenous bisphosphonates for bony metastases in patients with advanced breast cancer: Results in the off-trial setting', Journal of Clinical Oncology, vol. 23, pp. 6089 - 6089, http://dx.doi.org/10.1200/jco.2005.23.16_suppl.6089

Liauw WS; Segelov E; Lih A; Dunleavy M; Links MR; Ward RL, 2005, 'Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer', BMC Cancer, vol. 5, http://dx.doi.org/10.1186/1471-2407-5-89

Martin DI; Ward RL; Suter CM, 2005, 'Germline Epimutation:A basis for epigenetic disease in humans', Annals of the New York Academy of Sciences, vol. 1054, pp. 68 - 77, http://dx.doi.org/10.1196/annals.1345.009

Tothill R; Kowalczyk A; Rischin D; Bousioutas A; Haviv I; van Laar R; Waring P; Zalcberg JR; Ward RL; Biankin AV; Sutherland RL; Henshall SM; Fong KA; Pollack J; Bowtell D; Holloway A, 2005, 'An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin', Cancer research, vol. 65, pp. 4031 - 4040, http://dx.doi.org/10.1158/0008-5472.CAN-04-3617

Tothill RW; Kowalczyk A; Rischin D; Bousioutas A; Haviv I; Van Laar RK; Waring PM; Zalcberg J; Ward R; Biankin AV; Sutherland RL; Henshall SM; Fong K; Pollack JR; Bowtell D; Holloway AJ, 2005, 'Erratum: An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin (Cancer Research (May 15, 2005) 65 (4031-4040))', Cancer Research, vol. 65, pp. 8057

Ward RL; Turner J; Williams R; Pekarsky B; Packham D; Velickovic M; Meagher AP; O Connor TW; Hawkins NJ, 2005, 'Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified', Journal of Pathology, vol. 207, pp. 377 - 384, http://dx.doi.org/10.1002/path.1851

Ioannidis JPA; Awasthi S; Beardmore J; Clark J; Hadridge P; Madani H; Marusic A; Purcell G; Rhoads M; Silwa-Hahnle K; Smith R; Edejer TT; Tugwell P; Underwood T; Ward RL, 2004, 'Academic medicine: the evidence base', British Medical Journal: Clinical Research, vol. 329, pp. 789 - 792, http://dx.doi.org/10.1136/bmj.329.7469.789

Liauw WS; Ward R, 2004, 'Utilisation of Markov-Monte Carlo modelling to determine treatment strategies in advanced non-small cell lung cancer', Journal of Clinical Oncology, vol. 22, pp. 7125 - 7125, http://dx.doi.org/10.1200/jco.2004.22.14_suppl.7125

Liauw WS; Ward R, 2004, 'Utilisation of Markov-Monte Carlo modelling to determine treatment strategies in advanced non-small cell lung cancer', Journal of Clinical Oncology, vol. 22, pp. 7125 - 7125, http://dx.doi.org/10.1200/jco.2004.22.90140.7125

Lomas M; Liauw WS; Packham D; Williams KM; Kelleher AD; Zaunders J; Ward RL, 2004, 'Phase I clinical trial of a human idiotypic p53 vaccine in patients with advanced malignancy', Annals of Oncology, vol. 15, pp. 324 - 329, http://dx.doi.org/10.1093/annonc/mdh053

Meagher AP; Ward RL, 2004, 'Re: Evidence supports adjuvant radiotherapy in selected patients with rectal cancer', Australian and New Zealand Journal of Surgery, vol. 74, pp. 1123 - 1124, http://dx.doi.org/10.1111/j.1445-1433.2004.03277.x

Morgan GJ; Ward R; Barton MB, 2004, 'The contribution of cytoxic chemotheraoy to 5-year survival in adult malignancies', Clinical Oncology, vol. 16, pp. 549 - 560, http://dx.doi.org/10.1016/j.clon.2004.06.007

Suter CM; Martin DI; Ward RL, 2004, 'Germline epimutation of MLH1 in individuals with multiple cancers', Nature Genetics, vol. 36, pp. 497 - 501, http://dx.doi.org/10.1038/ng1342

Suter CM; Martin DI; Ward RL, 2004, 'Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue', International Journal of Colorectal Disease, vol. 19, pp. 95 - 101, http://dx.doi.org/10.1007/s00384-003-0539-3

Ward RL, 2004, 'ICRAM (the International Campaign to Revitalise Academic Medicine): agenda setting', BMJ: British Medical Journal, vol. 329, pp. 787 - 789, http://dx.doi.org/10.1136/bmj.329.7469.787

Ward RL; Mokany E, 2004, 'Germline testing of mismatch repair genes is not aided by prescreeningtumours for allelic loss', Gut, vol. 53, pp. 471 - 472, http://dx.doi.org/10.1136/gut.2003.031716

Ward RL; Williams R; Law MG; Hawkins NJ, 2004, 'The CpG island methylator phenotype is not associated with a personal or family history of cancer', Cancer research, vol. 64, pp. 7618 - 7621, http://dx.doi.org/10.1158/0008-5472.CAN-03-3978

Wilkinson DD; Ward RL, 2004, 'International Campaign to Revitalise Academic Medicine (ICRAM): what does it mean for Australia?', Medical Journal of Australia, vol. 181, pp. 658 - 659

Andreyev HJ; Benamouzig R; Beranek M; Cunningham D; Norman AR; Giaretti W; de Goeij A; Iacopetta BJ; Jullian E; Krtolica K; Lee JQ; Wang ST; Lees N; Al-Mulla F; Muller O; Pauly M; Pricolo VE; Russo A; Troungos C; Urosevic N; Ward RL, 2003, 'Mutant K-ras2 in serum', Gut, vol. 52, pp. 915 - 916, http://dx.doi.org/10.1136/gut.52.6.915

Bariol CM; Hawkins NJ; Turner JJ; Meagher AP; Williams DB; Ward RL, 2003, 'Histopathological and clinical evaluation of serrated adenomas of the colon and rectum', Modern Pathology, vol. 16, pp. 417 - 423, http://dx.doi.org/10.1097/01.MP.0000068236.47471.DB

Bariol CM; Suter CM; Cheong K; Ky L; Meagher AP; Hawkins NJ; Ward RL, 2003, 'The relationship between hypomethylation and CpG island methylation in colorectal neoplasia', American Journal of Pathology, vol. 162, pp. 1361 - 1371, http://dx.doi.org/10.1016/S0002-9440(10)63932-6

Brown DA; Ward RL; Buckhaults P; Liu T; Romans KE; Hawkins NJ; Bauskin AR; Kinzler KW; Vogelstein B; Breit SN, 2003, 'MIC 1 serum level and genotype: Associations with progress and prognosis of colorectal carcinoma', Clinical Cancer Research, vol. 9, pp. 2642 - 2650

Grieu F; Malaney S; Ward RL; Joseph D; Iacopetta BJ, 2003, 'Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers', Anticancer Research, vol. 23, pp. 4257 - 4260

Jass JR; Tomlinson I; Halford S; Aaltonen L; Hawkins N; Ward R, 2003, 'Re: Tomlinson et al. Does MSI-low exist. J Pathol 2002; 197: 6-13 (multiple letters)', Journal of Pathology, vol. 199, pp. 267 - 269, http://dx.doi.org/10.1002/path.1266

Liu T, 2003, 'Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum', Proceedings of the National Academy of Sciences of the United States of America, vol. 100, pp. 3410 - 3415, http://dx.doi.org/10.1073/pnas.0530278100

Meagher AP; Ward RL, 2003, 'Current evidence does not support routine adjuvant radiotherapy for rectal cancer: reply', ANZ JOURNAL OF SURGERY, vol. 73, pp. 661 - U7, http://dx.doi.org/10.1046/j.1445-2197.2003.t01-1-02720.x

Meagher AP; Ward RL, 2003, 'Letter to the Editor Current evidence does not support routine adjuvant radiotherapy for rectal cancer', Australian and New Zealand Journal of Surgery, vol. 73, pp. 252 - 253, http://dx.doi.org/10.1046/j.1445-2197.2003.t01-1-02575.x

Ngan SYK; Goldstein D; Solomon M; Zalcberg J; Meagher AP; Ward RL, 2003, 'Is improving local control sufficient indication for radiotherapy in the management of rectal cancer? A response [1] (multiple letters)', ANZ Journal of Surgery, vol. 73, pp. 660 - 661, http://dx.doi.org/10.1046/j.1445-2197.2003.t01-1-02719.x

Norrie M; Hawkins NJ; Todd AV; Meagher AP; O Connor TW; Ward RL, 2003, 'Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer', Journal of Surgical Oncology, vol. 84, pp. 143 - 150, http://dx.doi.org/10.1002/jso.10310

Quinn E; Hawkins NJ; Suter CM; Yip YL; Ward RL, 2003, 'CD103+ intraepithelial lymphocytes- a unique population in microsatellite unstable sporadic colorectal cancer', European Journal of Cancer, vol. 39, pp. 469 - 475, http://dx.doi.org/10.1016/S0959-8049(02)00633-0

Suter CM; Norrie M; Ku S; Cheong KF; Ward RL, 2003, 'CpG island methylation is a common finding in colorectal cancer cell lines', British Journal of Cancer, vol. 88, pp. 413 - 419, http://dx.doi.org/10.1038/sj.bjc.6600699

Tomlinson IP; Halford S; Aaltonen L; Hawkins NJ; Ward RL, 2003, 'Re: Tomlinson et al. Does MSI-low exist - Authors' reply.', Journal of Pathology, vol. 199, pp. 269 - 270, http://dx.doi.org/10.1002/path.1265

Ward RL, 2003, 'Antineoplastic antibodies- clinical applications', Australian Prescriber, vol. 26, pp. 141 - 143

Ward RL; Cheong K; Ku S; Meagher AP; O Connor TW; Hawkins NJ, 2003, 'Adverse Prognostic Effect of Methylation in Colorectal Cancer Is Reversed by Microsatellite Instability', Journal of Clinical Oncology, vol. 21, pp. 3729 - 3736, http://dx.doi.org/10.1200/JCO.2003.03.123

Yip YL; Novotny J; Edwards MR; Ward RL, 2003, 'Structural analysis of the ErbB-2 receptor using monoclonal antibodies: Implications for receptor signalling', International Journal of Cancer, vol. 104, pp. 303 - 309, http://dx.doi.org/10.1002/ijc.10951

Cuzick J, 2002, 'First results from the International Breast Cancer Intervention Study (IBIS-I): A randomised prevention trial', Lancet, vol. 360, pp. 817 - 824, http://dx.doi.org/10.1016/S0140-6736(02)09962-2

Davenport MP; Ward RL; Hawkins NJ, 2002, 'The null oncogene hypothesis and protection from cancer', Journal of Medical Genetics, vol. 39, pp. 12 - 14

Edwards MR; Brouwer W; Choi CH; Ruhno J; Ward RL; Collins AM, 2002, 'Analysis of IgE antibodies from a patient with atopic dermatitis: Biased V gene usage and evidence for polyreactive IgE heavy chain complementary-determining region 3', Journal of Immunology, vol. 168, pp. 6305 - 6313, http://dx.doi.org/10.4049/jimmunol.168.12.6305

Halford S; Sasieni P; Rowan A; Wasan H; Bodmer W; Talbot I; Hawkins NJ; Ward RL; Tomlinson IP, 2002, 'Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait.', Cancer research, vol. 62, pp. 53 - 57

Hawkins NJ; Norrie M; Cheong K; Mokany E; Ku S; Meagher AP; O Connor TW; Ward RL, 2002, 'CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability', Gastroenterology, vol. 122, pp. 1376 - 1387, http://dx.doi.org/10.1053/gast.2002.32997

Hughes CS; Alford J; Campbell LV; Rule M; Armstrong M; Such C; Ward RL, 2002, 'Caring for the chronically ill: a clinic for final-year medical students', Medical Teacher, vol. 24, pp. 564 - 566, http://dx.doi.org/10.1080/0142159021000042658

Humar B; Toro T; Graziano F; Muller HG; Dobbie Z; Kwang-Yang H; Eng C; Hampel H; Gilbert D; Winship I; Parry S; Ward RL, 2002, 'Novel germline CDH1 mutations in hereditary diffuse gastric cancer families', Human Mutation, vol. 19, pp. 518 - 525, http://dx.doi.org/10.1002/humu.10067

Maple-Brown L; Ward RL; Williams RA, 2002, 'Familial hypocalciuric hypercalcaemia in a large family with neurofibromatosis', Clinical Geriatrics, vol. 62, pp. 252 - 254, http://dx.doi.org/10.1034/j.1399-0004.2002.620313.x

Meagher AP; Ward RL, 2002, 'Current evidence does not support routine adjuvant radiotherapy for rectal cancer', Australian and New Zealand Journal of Surgery, vol. 72, pp. 835 - 840, http://dx.doi.org/10.1046/j.1445-2197.2002.02543.x

Morey AL; Wanigesekera D; Hawkins NJ; Ward RL, 2002, 'C-kit mutations in gastrointestinal stromal tumours', Pathology, vol. 34, pp. 315 - 319, http://dx.doi.org/10.1080/00313020220147122

Norrie M; Cheong K; Ku S; Mokany E; Todd A; Alan M; O'Connor T; Hawkins N; Ward R, 2002, 'Gene hypermethylation is a major determinant of phenotypic expression in colorectal cancer', GASTROENTEROLOGY, vol. 122, pp. A106 - A106, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000175366600531&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Norrie M; Hawkins NJ; Todd AV; Meagher AP; O Connor TW; Ward RL, 2002, 'The role hMLH1 methylation in the development of solitary and synchronous sporadic colorectal carcinomas', Diseases of the Colon and Rectum, vol. 45, pp. 674 - 680, http://dx.doi.org/10.1007/s10350-004-6266-1

Suter CM; Morgan GJ; Hanby A; Hawkins NJ; Ward RL, 2002, 'Clinicopathological correlates of GPIb-alpha expression in human breast cancers', Anticancer Research, vol. 22, pp. 1251 - 1256, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000177246300038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Tomlinson IP; Halford S; Aaltonen L; Hawkins NJ; Ward RL, 2002, 'Does MSI-low exist?', Journal of Pathology, vol. 197, pp. 6 - 13, http://dx.doi.org/10.1002/path.1071

Ward RL; Hawkins NJ, 2002, 'Medical oncology', Medical Journal of Australia, vol. 176, pp. 25, http://dx.doi.org/10.5694/j.1326-5377.2002.tb04258.x

Ward RL; Hawkins NJ, 2002, 'Updates in Medicine - Medical Oncology', Medical Journal of Australia, vol. 25, pp. 25 - 25

Ward RL; Hawkins NJ; Bariol C, 2002, 'The serrated neoplasia pathway', Pathology, vol. 34, pp. 548 - 555, http://dx.doi.org/10.1080/0031302021000035965

Ward RL; Meldrum C; Williams R; Mokany E; Scott R; Turner J; Hawkins NJ; Burgess B; Groombridge C; Spigelman A, 2002, 'Impact of microsatellite testing and mismatch repair protein expression on the clinical interpretation of genetic testing in hereditary non-polyposis colorectal cancer', Journal of Cancer Research and Clinical Oncology, vol. 128, pp. 403 - 411, http://dx.doi.org/10.1007/s00432-002-0361-2

Yip YL; Ward RL, 2002, 'Anti-ErbB-2 monoclonal antibodies and ErbB-2-directed vaccines', Cancer Immunology and Immunotherapy, vol. 50, pp. 569 - 587, http://dx.doi.org/10.1007/s002620100226

Yip YL; Ward RL, 2002, 'Application of phage display technology to cancer research', Current Pharmaceutical Biotechnology, vol. 3, pp. 29 - 43, http://dx.doi.org/10.2174/1389201023378472

Andreyev HJ; Norman AR; Cunningham D; Oates J; DIx BR; lacopetta BJ; Young J; Walsh T; Ward RL; Hawkins NJ; Beranek M; Jandik P; Benamouzig R; Jullian E; Laurent-Puig P; Olswang S; Muller O; Hoffman I; Rabes HM; Zietz C; Troungas C; Valavanis C; Yuen ST; Ho JW; Croke CT; O Donoghue DP; Giaretti W; Rapallo A; Russo A; Bazan V; Tanaka M; Omura K; Azuma T; Ohkusa T; Fujimori T; Pauly M; Ono Y; Faber C; Glaesener R; de Goeji A; Arends JW; Andersen SN; Lovig T; Breivik J; Gaudernack G; Clausen OP; De Angelis P; Meling GI; Rognum TO; Smith R; Goh H; Font A; Rosell R; Sun XF; Zhang H; Benhattar J; Losi L; Lee JQ; Wang ST; Clarke PA; Bell S; Quirke P; Bubb VJ; Piris J; Cruickshank NR; Morton D; Fox JC; Al-Mulla F; Lees N; Hall CN; Snary D; Wilkinson K; Dillon D; Costa J; Senagore AJ; Pricolo VE; Finkelstein SD; Thebo JS; Halter SA; Wadler S; Malik S; Krtolica K; Urosevic N, 2001, 'Kirsten ras mutations in patients with colorectal cancer: the `RASCAL II` study.', British Journal of Cancer, vol. 85, pp. 692 - 696, http://dx.doi.org/10.1054/bjoc.2001.1964

Bariol C; Field AS; Vickers CR; Ward RL, 2001, 'Regression of gastric T cell lymphoma with eradication of Helicobacter pylori', Gut, vol. 48, pp. 269 - 271, http://dx.doi.org/10.1136/gut.48.2.269

Coomber DW; Ward RL, 2001, 'Isolation of human antibodies against the central DNA binding domain of p53 from an individual with colorectal cancer using antibody phage display', Clinical Cancer Research, vol. 7, pp. 2802 - 2808

Edwards MR; Collins AM; Ward RL, 2001, 'The application of phage display in allergy research:characterization of IgE, identification of allergens and development of novel therapeutics', Current Pharmaceutical Biotechnology, vol. 2, pp. 225 - 240, http://dx.doi.org/10.2174/1389201013378653

Hawkins NJ; Tomlinson I; Meagher AP; Ward RL, 2001, 'Microsatellite-stable diploid carcinoma: A biologically distinct and aggressive subset of sporadic colorectal cancer', British Journal of Cancer, vol. 84, pp. 232 - 236, http://dx.doi.org/10.1054/bjoc.2000.1554

Hawkins NJ; Tomlinson I; Ward RL, 2001, 'Biological significance of microsatellite instability-low (MSI-L) status in colorectal tumors', American Journal of Pathology, vol. 158, pp. 780 - 781, http://dx.doi.org/10.1016/S0002-9440(10)64020-5

Hawkins NJ; Ward RL, 2001, 'Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas', Journal of the National Cancer Institute, vol. 93, pp. 1307 - 1313, http://dx.doi.org/10.1093/jnci/93.17.1307

Suter CM; Hogg PJ; Price JT; Chong BH; Ward RL, 2001, 'Identification and characterisation of a platelet GPIb/V/IX-like complex on human breast cancers: Implications for the metastatic process', Japanese Journal of Cancer Research, vol. 92, pp. 1082 - 1092, http://dx.doi.org/10.1111/j.1349-7006.2001.tb01063.x

Ward RL; Hawkins NJ, 2001, 'Checking the scoreboard: The impact of cancer genetics on clinical practice.', Internal Medicine Journal, vol. 31, pp. 249 - 253, http://dx.doi.org/10.1046/j.1445-5994.2001.00051.x

Ward RL; Meagher AP; Tomlinson I; O Connor TW; Norrie M; Wu R; Hawkins NJ, 2001, 'Microsatellite instability and the clinicopathological features of sporadic colorectal cancer', Gut, vol. 48, pp. 821 - 829, http://dx.doi.org/10.1136/gut.48.6.821

Yip YL; Smith G; Koch J; Dubel S; Ward RL, 2001, 'Identification of epitope regions recognized by tumor inhibitory and stimulatory anti-ErbB-2 monoclonal antibodies: Implications for vaccine design', Journal of Immunology, vol. 166, pp. 5271 - 5278, http://dx.doi.org/10.4049/jimmunol.166.8.5271

Yip YL; Smith G; Ward RL, 2001, 'Comparison of phage pIII, PVIII and GST as carrier proteins for peptide immunisation in Balb/c mice.', Immunology Letters, vol. 79, pp. 197 - 202, http://dx.doi.org/10.1016/S0165-2478(01)00281-4

Fuery CJ; Impey H; Roberts NK; Applegate TL; Ward RL; Hawkins NJ; Sheehan C; O Grady R; Todd AV, 2000, 'Detection of rare mutant alleles by restriction endonuclease-mediated selective-PCR: assay design and optimization', Clinical Chemistry, vol. 46, pp. 620 - 624

Hammond F; Cavanagh A; Morton H; Hillyard N; Papaioannou A; Clark M; Wanigesekera D; Swanton M; Ward R, 2000, 'Isolation of antibodies which neutralise the activity of early pregnancy factor', Journal of Immunological Methods, vol. 244, pp. 175 - 184, http://dx.doi.org/10.1016/S0022-1759(00)00235-0

Hawkins NJ; Gorman P; Tomlinson IP; Bullpitt P; Ward RL, 2000, 'Colorectal carcinomas arising in the hyperplastic polyposis syndrome progress through the chromosomal instability pathway', American Journal of Pathology, vol. 157, pp. 385 - 392, http://dx.doi.org/10.1016/S0002-9440(10)64551-8

Lord RS; Frommer DJ; Inder SJ; Tran D; Ward RL, 2000, 'Prevalence of Helibacter pylori infection in 160 patients with Barrett`s oesophagus or Barrett`s adencarcinoma', Australian and New Zealand Journal of Surgery, vol. 70, pp. 26 - 33, http://dx.doi.org/10.1046/j.1440-1622.2000.01737.x

Lord RS; O Grady R; Sheehan C; Field AS; Ward RL, 2000, 'Barrett's oesophagus and cancer: K-ras codon 12 mutations in Barrett's oesophagus and adenocarcinomas of the oesophagus and oesophagogastric junction', Journal of Gastroenterology and Hepatology, vol. 15, pp. 730 - 736, http://dx.doi.org/10.1046/j.1440-1746.2000.02163.x

Perry TS; Davidson SJ; Serduke FJD; Bach DR; Smith CC; Foster JM; Doyas RJ; Ward RA; Iglesias CA; Rogers FJ; Abdallah J; Stewart RE; Wallace RJ; Kilkenny JD; Lee RW, 2000, 'Opacity measurements in a hot dense medium', Astrophysical Journal, Supplement Series, vol. 127, pp. 433 - 436, http://dx.doi.org/10.1086/313368

Shannon C; Vickers C; Field A; Ward R, 2000, 'Burkitt's lymphoma associated with Helicobacter pylori', Journal of Gastroenterology and Hepatology (Australia), vol. 15, pp. 99 - 103, http://dx.doi.org/10.1046/j.1440-1746.2000.02039.x

Ward RL; Packham D; Smythe AM; Anderson-Stewart P; Kitchen NA; Phillips P; Gray PP; Prabakaran K; Freund J; Fullham M; Rule M; Dalley D; Meagher AP; Hawkins NJ; Smith G, 2000, 'Phase I clinical trial of the chimeric monoclonal antibody (c30.6) in patients with metastatic colorectal cancer', Clinical Cancer Research, vol. 6, pp. 4674 - 4683, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000166160200013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Ward RL; Sheehan C; Norrie M; Applegate TL; Fuery CJ; Impey H; Hawkins NJ; Todd AV, 2000, 'Factors influencing the detection of mutant K-ras in the serum of patients with colorectal cancer', Annals of the New York Academy of Sciences, vol. 906, pp. 17 - 18, http://dx.doi.org/10.1111/j.1749-6632.2000.tb06583.x

Chamberlain NL; Ward RL; Hawkins NJ, 1999, 'Clinicopathological significance of erbB-2 expression in colorectal cancer', Oncology Reports, vol. 6, pp. 527 - 531

Coomber DW; Hawkins NJ; Clark MA; Ward RL, 1999, 'Generation of anti-p53 Fab fragments from individuals with colorectal cancer using phage display', Journal of Immunology, vol. 163, pp. 2276 - 2283

Roberts NJ; Impey H; Applegate TL; Furey C; Ward RL; Todd AV, 1999, 'Rapid and sensitive detection of mutant alleles in codon 12 of K-ras by restriction endonuclease-mediated selective polymerase chain reaction (REMS-PCR)', BioTechniques, vol. 27, pp. 418 - 422

Ward RL; Hawkins NJ; Coomber DW; Disis ML, 1999, 'Antibody immunity to the HER-2/neu oncogenic protein in patients with colorectal cancer', Human Immunology, vol. 60, pp. 510 - 515, http://dx.doi.org/10.1016/S0198-8859(99)00003-8

Yip YL; Hawkins NJ; Smith G; Ward RL, 1999, 'Biodistribution of filamentous phage-Fab in nude mice', Journal of Immunological Methods, vol. 225, pp. 171 - 178, http://dx.doi.org/10.1016/S0022-1759(99)00044-7

Yip YL; Ward RL, 1999, 'Epitope discovery using monoclonal antibodies and phage peptide libraries. Combinatorial chemistry and high throughput screening', Combinatorial Chemistry and High Throughput Screening, vol. 2, pp. 125 - 138

Zahra DG; Vancov A; Dunn JM; Hawkins NJ; Ward RL, 1999, 'Selectable in vivo recombination to increase antibody library size - an improved phage display vector system', Gene, vol. 227, pp. 49 - 54, http://dx.doi.org/10.1016/S0378-1119(98)00593-9

Coomber DW; Hawkins NJ; Dalley D; Ward RL, 1998, 'The significance of anti-sialyl-Tn antibodies in patients with colorectal or breast cancer', Neoplasma, vol. 45, pp. 12 - 16, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000072742800003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Hawkins NJ; Ward RL, 1998, 'Phage display: evolving proteins in vitro.', Today's Life Science, vol. 10, pp. 32 - 36

Lord RS; Law MG; Ward RL; Giles G; Thomas R; Thursfield V, 1998, 'Rising incidence of oesophageal adenocarcinoma in men in Australia.', Journal of Gastroenterology and Hepatology, vol. 13, pp. 356 - 362, http://dx.doi.org/10.1111/j.1440-1746.1998.tb00646.x

Ward RL; Hawkins NJ; O Grady R; Sheehan C; O Connor TW; Impey H; Furey C; Todd AV; Roberts N, 1998, 'Restriction endonuclease-mediated selective polymerase chain reaction. A novel assay for the detection of K-ras mutations in clinical samples.', American Journal of Pathology, vol. 153, pp. 373 - 379, http://dx.doi.org/10.1016/S0002-9440(10)65581-2

Clark MA; Hammond F; Papaioannou A; Hawkins NJ; Ward RL, 1997, 'Regulation and expression of human Fabs under the control of the Escherichia coli arabinose promoter PBAD', Immunotechnology, vol. 3, pp. 217 - 226, http://dx.doi.org/10.1016/S1380-2933(97)00016-X

Clark MA; Hawkins NJ; Papaioannou A; Fiddes RJ; Ward RL, 1997, 'Isolation of human anti-c-erBB-2 FaBs from a lymph node-derived phage display liBrary', Clinical and Experimental Immunology, vol. 109, pp. 166 - 174, http://dx.doi.org/10.1046/j.1365-2249.1997.4161316.x

Hawkins NJ; Lees J; Hargrave R; O Connor TW; Meagher AP; Ward RL, 1997, 'Pathological and genetic correlates of apoptosis in the progression of colorectal neoplasia', Tumor Biology, vol. 18, pp. 146 - 156, http://dx.doi.org/10.1159/000218025

Hawkins NJ; Lees J; Ward RL, 1997, 'Detection of apoptosis in colorectal carcinoma Bylight microscopy and in-situ end-laBelling', Analytical and Quantitative Cytology and Histology, vol. 19, pp. 227 - 232

Hawkins NJ; Ward RL; Smith L, 1997, 'The images of disease project; a computer-Based aid to the teaching of pathology', Medical Teacher, vol. 19, pp. 45 - 50, http://dx.doi.org/10.3109/01421599709019347

Maclean A; Symonds GP; Ward RL, 1997, 'Immunoliposomes as targeted delivery vehicles for cancer therapeutics', International Journal of Oncology, vol. 11, pp. 325 - 332

Meagher AP; Ward RL, 1997, 'Advances in the treatment of colorectal carconoma', Modern Medicine of Australia, vol. 40, pp. 22 - 29

Santiago FS; Todd AV; Hawkins NJ; Ward RL, 1997, 'Detection of K-ras point mutation by enriched PCR-colorimetric plate assay', Molecular and Cellular Probes, vol. 11, pp. 33 - 38, http://dx.doi.org/10.1006/mcpr.1996.0073

Smith G; Biggs J; Norris B; Anderson-Stewart P; Ward RL, 1997, 'Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthitis', Journal of Clinical Immunology, vol. 17, pp. 502, http://dx.doi.org/10.1023/A:1027327912204

Ward R, 1997, 'Genetics and cancer (Part 1): Overview', Cancer Forum, vol. 21, pp. 2

Ward RL; Hawkins NJ; Smith G, 1997, 'Antibody therapy in solid tumours; lessons from the clinic', Cancer Treatment Reviews, pp. 305 - 319

Ward RL; Todd AV; Santiago FS; O Connor TW; Hawkins NJ, 1997, 'Activation of the K-ras oncogene in colorectal neoplasms is associated with decreased apoptosis', Cancer, vol. 79, pp. 1106 - 1113, http://dx.doi.org/10.1002/(SICI)1097-0142(19970315)79:6<1106::AID-CNCR8>3.0.CO;2-D

Yip YL; Hawkins NJ; Clark MA; Ward RL, 1997, 'Evaluation of different lymphoid tissue sources for the construction of human immunoglobulin gene libraries', Immunotechnology, vol. 3, pp. 195 - 203, http://dx.doi.org/10.1016/S1380-2933(97)00013-4

Coomber DW; Hawkins NJ; Clark MA; Meagher AP; Ward RL, 1996, 'Characterisation and clinicopathological correlates of serum anti-p53 antibodies in breast and colon cancer', Journal of Cancer Research and Clinical Oncology, vol. 122, pp. 757 - 762, http://dx.doi.org/10.1007/BF01209124

Depczynski B; Ward R; Eisman J, 1996, 'The association between myxedematous ascites and extreme elevation of serum tumor markers [2]', Journal of Clinical Endocrinology and Metabolism, vol. 81, pp. 4175, http://dx.doi.org/10.1210/jcem.81.11.8923881

Dolnikov A; Ward RL; Hawkins NJ; Symonds G, 1996, 'Apoptosis in v-myc transformation of myelomonocytic cells and its modulation by CSF-1', Oncogene, vol. 12, pp. 1189 - 1198

Hawkins NJ; Lees J; Kearney PP; Clark MA; Golovsky D; Ward RL, 1996, 'Biological properties of renal oncocytoma cells in culture', Urologia Internationalis, vol. 56, pp. 69 - 74, http://dx.doi.org/10.1159/000282814

Perry TS; Springer PT; Fields DF; Bach DR; Serduke FJD; Iglesias CA; Rogers FJ; Nash JK; Chen MH; Wilson BG; Goldstein WH; Rozsynai B; Ward RA; Kilkenny JD; Doyas R; Da Silva LB; Back CA; Cauble R; Davidson SJ; Foster JM; Smith CC; Bar-Shalom A; Lee RW, 1996, 'Absorption experiments on x-ray-heated mid-Z constrained samples', Physical Review E - Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics, vol. 54, pp. 5617 - 5631, http://dx.doi.org/10.1103/PhysRevE.54.5617

Ward RL; Clark MA; Lees J; Hawkins NJ, 1996, 'Retrieval of human antibodies from phage-display libraries using enzymatic elution', Journal of Immunological Methods, vol. 189, pp. 73 - 82, http://dx.doi.org/10.1016/0022-1759(95)00231-6

Al-Moundhri M; Ezzie J; Ward RL, 1995, 'Rectal administration of ondansetron in uncontrolled emesis induced by chemotherapy', Australian and New Zealand Journal of Medicine, vol. 25, pp. 538 - 538, http://dx.doi.org/10.1111/j.1445-5994.1995.tb01504.x

Dolnikov A; Yi S; Hawkins NJ; Ward RL; Symonds G, 1995, 'Transformation by v-erb-B: induction of apoptosis is abrogated in a myeloid cell line', International Journal of Oncology, vol. 6, pp. 633 - 638

Perry TS; Budil KS; Cauble R; Ward RA; Bach DR; Iglesias CA; Wilson BG; Nash JK; Smith CC; Foster JM; Davidson SJ; Serduke FJD; Kilkenny JD; Lee RW, 1995, 'Quantitative measurement of mid-z opacities', Journal of Quantitative Spectroscopy and Radiative Transfer, vol. 54, pp. 317 - 324, http://dx.doi.org/10.1016/0022-4073(95)00066-T

Ward RL; Santiago FS; Hawkins NJ; Coomber DW; O Connor TW; Todd AV, 1995, 'A rapid PCR ELISA for the detection of activates K-ras in colorectal cancer', Journal of Clinical Pathology, vol. 48, pp. 273 - 277, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995RZ58000009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Hawkins NJ; Ward RL; Wakefield D, 1994, 'Cytokine-mediated induction of HLA antigen expression on human glomerular mesangial cells', Cellular Immunology, vol. 155, pp. 493 - 500, http://dx.doi.org/10.1006/cimm.1994.1141

Perry TS; Ward RA; Bach DR; Doyas RJ; Hammel BA; Phillion DW; Kornblum HN; Foster JM; Rosen PA; Wallace RJ; Kilkenny JD, 1994, 'Experimental techniques to measure thermal radiation heat transfer', Journal of Quantitative Spectroscopy and Radiative Transfer, vol. 51, pp. 273 - 280, http://dx.doi.org/10.1016/0022-4073(94)90089-2

WARD RL; HENNIKER AJ; SMITH G; BRADSTOCK KF; ATKINSON K; BIGGS JC, 1994, 'Characterization of a novel leucocyte surface membrane antigen recognized by the monoclonal antibody WM65', Immunology and Cell Biology, vol. 72, pp. 49 - 55, http://dx.doi.org/10.1111/j.1440-1711.1994.tb03756.x

Ward RL; Hawkins NJ, 1993, 'Recombinant antibodies: back to the future', The Australian and New Zealand Journal of Medicine, vol. 23, pp. 393 - 403, http://dx.doi.org/10.1111/j.1445-5994.1993.tb01441.x

Ward RL; Hawkins NJ; Wakefield D; Atkinson K; Biggs J, 1993, 'Production of a functional single-chain Fv fragment from the pan-leukocyte antibody WM65 using splicing by asymmetric PCR', British Journal Haematology, vol. 21, pp. 660 - 664, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993MW61000011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Ward RL; Morgan G; Dalley D; Kelly PJ, 1993, 'Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women', Bone and Mineral, vol. 22, pp. 87 - 94, http://dx.doi.org/10.1016/S0169-6009(08)80220-6

Smith GM; Ward RL; Mcguigan L; Rajkovic IA; Scott KF, 1992, 'Measurement of human phospholipase a in arthritis plasma using a newly developed sandwich elisa', Rheumatology, vol. 31, pp. 175 - 178, http://dx.doi.org/10.1093/rheumatology/31.3.175

Perry TS; Davidson SJ; Serduke FJD; Bach DR; Smith CC; Foster JM; Doyas RJ; Ward RA; Iglesias CA; Rogers FJ; Abdallah J; Stewart RE; Kilkenny JD; Lee RW, 1991, 'Opacity measurements in a hot dense medium', Physical Review Letters, vol. 67, pp. 3784 - 3787, http://dx.doi.org/10.1103/PhysRevLett.67.3784

Kelly PJ; Atkinson K; Ward RL; Sambrook PN; Biggs JC; Eisman JA, 1990, 'Reduced bone mineral density in men and women with allogeneic bone marrow transplantation', Transplantation, vol. 50, pp. 881 - 883, http://dx.doi.org/10.1097/00007890-199011000-00028

Ward R; Conner G; Delprado W; Dalley D, 1989, 'Metastatic adenocarcinoma of the cervix presenting as an inflammatory breast lesion', Gynecologic Oncology, vol. 35, pp. 399 - 405, http://dx.doi.org/10.1016/0090-8258(89)90088-7

Sandhu G; Adattini J; O'Neill N; Armstrong Gordon E; Kelly A; Shingleton J; Liauw WS; Ward RL, 2022, 'International consensus guideline for anticancer drug dosing in kidney dysfunction (ADDIKD): A standardized approach to assessing kidney function in cancer patients and its application to anticancer drug dosing.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 40, pp. e13518 - e13518, http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e13518

Nic Giolla Easpaig B; Tran Y; Bierbaum M; Arnolda G; Delaney GP; Liauw W; Ward RL; Olver I; Currow D; Girgis A; Durcinoska I; Braithwaite J, 2020, 'What are the attitudes of health professionals regarding patient reported outcome measures (PROMs) in oncology practice? A mixed-method synthesis of the qualitative evidence', in BMC Health Services Research, WILEY, pp. 205 - 206, http://dx.doi.org/10.1186/s12913-020-4939-7

Poulos RC; Perera D; Packham D; Shah A; Janitz C; Pimanda JE; Hawkins N; Ward RL; Hesson LB; Wong JWH, 2018, In search of non-coding driver mutations by deep sequencing of regulatory elements in colorectal cancer, http://dx.doi.org/10.1101/249300

Chandrakanthan V; Yeola A; Kwan JC; Oliver RA; Qiao Q; Kang YC; Zarzour P; Beck D; Boelen L; Unnikrishnan A; Villanueva JE; Nunez AC; Knezevic K; Palu C; Nasrallah R; Carnell M; Macmillan A; Whan R; Yu Y; Hardy P; Grey ST; Gladbach A; Delerue F; Ittner L; Mobbs R; Walkley CR; Purton LE; Ward RL; Wong JWH; Hesson LB; Walsh W; Pimanda JE, 2016, 'PDGF-AB and 5-Azacytidine induce conversion of somatic cells into tissue-regenerative multipotent stem cells', in PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, NATL ACAD SCIENCES, Vol. 113, pp. E2306 - E2315, http://dx.doi.org/10.1073/pnas.1518244113

Jonnagaddala J; Croucher JL; Jue TR; Meagher NS; Caruso L; Ward R; Hawkins NJ, 2016, 'Integration and Analysis of Heterogeneous Colorectal Cancer Data for Translational Research', in Nursing Informatics 2016, pp. 387 - 387, http://dx.doi.org/10.3233/978-1-61499-658-3-387

Lewin J; Vis DJ; Lawler M; Liao R; Mao M; Teh BT; Sellers W; Ward R; Camargo AA; Andre F; Schilsky R; Lacombe D; Shibata T; Fox S; Le Tourneau C; Dalton WS; Knoppers BM; Sawyers C; Voest EE; Siu LL, 2016, 'Abstract 1832: Large variations in clinical and ethical aspects of genomic sequencing initiatives: A Global Alliance for Genomics and Health (GA4GH) survey', in Cancer Research, American Association for Cancer Research (AACR), pp. 1832 - 1832, presented at Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA, http://dx.doi.org/10.1158/1538-7445.am2016-1832

Chen Y; Peate M; Wong T; Meiser B; Kirk J; Ward R; Goodwin A; Hiller J; Trainer A; Macrae F; Mitchell G, 2015, 'Exploring clinicians’ attitudes about using aspirin for risk reduction in people with Lynch Syndrome (LS) without personal diagnosis of colorectal cancer', in Abstracts for the 39th Human Genetics Society of Australasia Annual Scientific Meeting, presented at 39th Human Genetics Society of Australasia Annual Scientific Meeting, http://dx.doi.org/10.1017/thg.2015.45

Jitendra Jonnagaddala NJH, 2015, 'Integrating biospecimen, clinical, imaging and biomarker data to support translational research: A preliminary study in colorectal cancer', in Biobanking Stakeholder Network Symposium, 22 May 2015, Sydney, Australia

Jonnagaddala J; Croucher JL; Meagher NS; Kumar M; Caruso L; Jue TR; London J; Ward RL; Hawkins NJ, 2015, 'Supporting translational research: Accessing colorectal cancer research data', in Australian Open Research Data Showcase, Canberra, Australia

Liang R; Meiser B; Smith S; Kasparian N; Lewis C; Chin M; Long G; Ward R; Menzies A; Gumniski A; Harris J; Kaur R, 2015, 'Oncology patients’ attitudes toward, and experiences with, somatic mutation tumour testing', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, Tasmania, Australia, Vol. 11, pp. 144 - 144, presented at Clinical Oncology Society of Australia 42nd Annual Meeting, Tasmania, Australia, 17 December 2015 - 19 November 2015, http://dx.doi.org/10.1111/ajco.12432_2

Sloane M; Liu Q; Nunez A; Packham D; Kwok C-T; Suthers G; Du Sart D; Williams R; Hesson L; Ward R, 2015, 'TRANSLATING BASIC RESEARCH INTO THE CLINICAL MANAGEMENT OF FAMILIES WITH LYNCH SYNDROME', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, Vol. 11, pp. 102 - 102, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364320800126&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Adelstein B-A; Venkateswaran R; Laaksonen MA; Ward RL, 2014, 'DOES HER2 AFFECT PROGNOSIS IN OESOPHAGEAL AND GASTRIC CANCER: A SYSTEMATIC REVIEW', Vol. 10, pp. 38 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346343700107&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Caruso L; Ward RL, 2014, 'ESTABLISHING A TRANSLATIONAL CANCER RESEARCH PROGRAM BY DEVELOPING RESEARCH INFRASTRUCTURE AND INFLUENCING SYSTEM CHANGES', Vol. 10, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346343700065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ford CE; Henry CE; Llamosas E; Djordjevic A; Hacker NF; Heinzelmann-Schwarz VA; Ward RL, 2014, 'HEAR THE ROR! THE ROLE OF WNT SIGNALLING IN OVARIAN CANCER', Vol. 24, pp. 952 - 952, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966501261&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harris C; Daniels B; Ward R; Pearson S-A, 2014, 'Do Pharmaceutical Claims Accurately Reflect Oncology Prescribing Practice: Evidence from an Australian HER2+Early Breast Cancer Cohort (HER2EBC)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 465 - 466, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342763600858&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harris C; Pearson S-A; Daniels B; Ward R, 2014, 'HER2 Positive Early Breast Cancer (HER2EBC): An Australian Patterns of Care Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, pp. 468 - 468, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342763600863&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harris M; Weller D; Ward R; Chin M; Meiser B; Crowley M, 2014, 'ATTITUDES TO CANCER FOLLOW-UP CARE IN GENERAL PRACTICE', Vol. 10, pp. 65 - 65, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346343700190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jacob F; Hitchins MP; Fedier A; Brennan K; Nixdorf S; Hacker NF; Ward R; Heinzelmann-Schwarz V, 2014, 'TRANSCRIPTIONAL SILENCING OF FORSSMAN SYNTHETASE IS REGULATED BY DNA METHYLATION IN OVARIAN CANCER', in INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, LIPPINCOTT WILLIAMS & WILKINS, pp. 238 - 239, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344966500188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jun S; Quinn C; Caruso L; Ward RL, 2014, 'CONSUMER ENGAGEMENT IN CANCER RESEARCH: DEVELOPMENT OF A CONSUMER ADVISORY COMMITTEE FOR RESEARCHERS IN SYDNEY, AUSTRALIA', Vol. 10, pp. 150 - 150, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346343700454&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Meagher NS; Scott G; Hettiaratchi A; Schwensen J; Jonnagaddala J; Caruso L; Ward RL; Crowe P; Salisbury E; Liauw W; others , 2014, 'Two years, fifteen hundred consents and counting. Integrating the HSA Biobank within routine clinical practice within the SESLHD.', in Innovations in Cancer Treatment and Care, Sydney, Australia, 17 October 2014.

Pearce AM; Haas M; Viney R; Ward R; Haywood P, 2014, 'RATES OF CHEMOTHERAPY ADVERSE-EVENTS IN CLINICAL PRACTICE: RESULTS FROM PROSPECTIVE COHORT STUDY', Vol. 10, pp. 43 - 44, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346343700124&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Peng J; Liu JJ; Daniels B; Firriolo J; Laaksonen MA; Hawkins NJ; Meagher AP; Hayes I; Croxford M; Cai S; Ward RL, 2014, 'RETROSPECTIVE COMPARISON OF RECTAL CANCER TREATMENT IN CHINA AND AUSTRALIA FROM 1995-2012', Vol. 10, pp. 106 - 106, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345350900095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vajdic CM; Schaffer A; Dobbins TA; Barrett J; Ward RL; Er CC; Pearson S-A, 2014, 'HEALTH SERVICE UTILISATION AND INVESTIGATIONS BEFORE DIAGNOSIS OF CANCER OF UNKNOWN PRIMARY (CUP): A POPULATION-BASED NESTED CASE-CONTROL STUDY', Vol. 10, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vajdic CM; Schaffer A; Dobbins TA; Ward RL; Barrett J; Er CC; Pearson S-A, 2014, 'Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study', Vol. 10, pp. 203 - 203, presented at 2014 World Cancer Congress, Melbourne, 03 December 2014 - 06 December 2014, http://dx.doi.org/10.1111/ajco.12332

Harris C; Daniels B; Ward R; Pearson S-A, 2013, 'DO PHARMACEUTICAL CLAIMS ACCURATELY REFLECT ONCOLOGY PRESCRIBING PRACTICE: EVIDENCE FROM AN AUSTRALIAN HER2+EARLY BREAST CANCER COHORT (HER2EBC)', Vol. 9, pp. 123 - 123, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800200&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harris C; Pearson S-A; Daniels B; Srasuebkul P; Ward R, 2013, 'HER2 POSITIVE EARLY BREAST CANCER (HER2EBC): AN AUSTRALIAN PATTERN OF CARE STUDY', Vol. 9, pp. 81 - 81, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harris CA; Pearson S; Daniels B; Srasuebkul P; Ward RL, 2013, 'HER2-positive early breast cancer (HER2EBC): An Australian pattern of care study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Diego, presented at ASCO's Quality Care Symposium, CA, San Diego, 01 November 2013 - 02 November 2013, http://dx.doi.org/10.1200/jco.2013.31.31_suppl.101

Harris CA; Ward RL; Daniels B; Pearson S, 2013, 'Do pharmaceutical claims accurately reflect oncology prescribing practice? Evidence from an Australian HER2+early breast cancer cohort ( HER2EBC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Diego, presented at ASCO's Quality Care Symposium, CA, San Diego, 01 November 2013 - 02 November 2013, http://dx.doi.org/10.1200/jco.2013.31.31_suppl.100

Nanda KS; Burgess NG; Williams SJ; Singh R; Hourigan LF; Zanati SA; Brown GJ; Ward RL; Sonson R; Acharya P; Byth K; Bourke MJ, 2013, 'Phenotypic expression of large (>= 20 mm) sessile serrated adenomas of the colon referred for wide field endoscopic mucosal resection in a multicenter prospective cohort', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 26 - 27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Patil V; Sloane M; Wong JWH; Liu J; Nunez AC; Ward RL; Hesson LB, 2013, 'Gene resilencing following decitabine therapy is initiated by nucleosome reoccupancy and is related to CpG island shore methylation', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S171 - S171, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, NETHERLANDS, Amsterdam, 27 September 2013 - 01 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843601105&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Patil V; Sloane MA; Wong JW; Liu J; Ward RL; Hesson LB, 2013, 'Abstract 2983: Gene resilencing following decitabine therapy is initiated by nucleosome reoccupancy and is related to CpG island shore methylation.', in Cancer Research, American Association for Cancer Research (AACR), pp. 2983 - 2983, presented at Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC, http://dx.doi.org/10.1158/1538-7445.am2013-2983

Schaffer AL; Pearson S-A; Dobbins T; Er C; Meagher NS; Barrett J; Ward RL; Vajdic CM, 2013, 'HEALTH SERVICE USE, TREATMENT PATTERNS, AND SURVIVAL FOR CANCER OF UNKNOWN PRIMARY: A DATA LINKAGE STUDY', Vol. 9, pp. 98 - 98, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800129&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ward , 2013, 'Population-Based Molecular Screening for Lynch Syndrome: Implications for Personalized Medicine (vol 31, pg 2554, 2013)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Vol. 31, pp. 4167 - 4167, http://dx.doi.org/10.1200/JCO.2013.53.9056

Liu J; Hesson LB; Meagher AP; Bourke MJ; Hawkins NJ; Rand KN; Molloy PL; Pimanda JE; Ward RL, 2012, 'Relative distribution of folate species is associated with global DNA methylation in human colorectal mucosa', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Vol. 72, http://dx.doi.org/10.1158/1538-7445.AM2012-3125

Lu CY; Ward R, 2012, 'A COMPARATIVE STUDY OF THE MULTIPLE TECHNOLOGY ASSESSMENT PROCESS IN THE UK AND AUSTRALIA', Vol. 15, pp. A316 - A316, http://dx.doi.org/10.1016/j.jval.2012.08.697

Sloane M; Hesson L; Wong J; Pimanda J; Bourke M; Hawkins N; Ward R, 2012, 'Inactivation of the deubiquitinase USP44 is an early event in the formation of colorectal cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, http://dx.doi.org/10.1158/1538-7445.AM2012-LB-375

Venkateswaran R; Adelstein B; Falster M; Ward R, 2012, 'IS TUMOUR HER-2 STATUS A PROGNOSTIC FACTOR IN GASTRIC AND OESOPHAGEAL CANCERS? A SYSTEMATIC REVIEW', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 59 - 59, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000306960100051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hains I; Marks D; Ward RL; Aranda S; Rushton S; Braithwaite J, 2011, Medical electronic systems in oncology: A review of the literature, Centre for Clinical Governance Research, Australian Institute of Health Innovation, University of New South Wales, Sydney, Medical electronic systems in oncology: A review of the literature

Kuroiwa-Trzmielina J; Hawkins NJ; Ward RL; Hitchins MP, 2011, 'Constitutional MGMT promoter methylation and allelic expression imbalance are associated with the c.-56C > T (rs16906252) variant', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, http://dx.doi.org/10.1158/1538-7445.AM2011-60

Lu CY; Srasuebkul P; Drew A; Chen K; Ward R; Pearson S-A, 2011, 'Cardiotoxic Cancer Therapies in Australia: Which Patients Are Assessed for Cardiac Function?', Vol. 20, pp. S248 - S248, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294946600550&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Metz AJ; Bourke MJ; Moss A; Hesson L; Ward R, 2011, 'A Correlation of the Endoscopic Characteristics of Colonic Laterally Spreading Tumours (LSTS) With Genetic Mutations', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, IL, Chicago, pp. S191 - S191, presented at Conference on Digestive Disease Week 2011, IL, Chicago, 07 May 2011 - 10 May 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290167300770&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rapkins R; Kwok C; Ward RL; Hitchins MP, 2011, 'Functional analysis of a germline promoter variant to determine its role in epigenetic silencing of MLH1 in a Lynch syndrome family', Vol. 10, pp. S1 - S1, http://dx.doi.org/10.1007/s10689-011-9424-3

Arkenau H; Dobbins T; Nordman IC; Ward RL, 2010, 'Surrogate marker (SM) reporting in patients (pts) with advanced colorectal cancer (ACRC) of first-line clinical trials: It's time for standardized WO endpoint reporting.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.e14010

Ford CE; Tuomela J; Hedditch EL; Axelsson L; Liu Q; Ward RL; Harkonen P; Andersson T, 2010, 'Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, NORWAY, Oslo, pp. 11 - 11, presented at 21st Meeting of the European-Association-for-Cancer-Research, NORWAY, Oslo, 26 June 2010 - 29 June 2010, http://dx.doi.org/10.1016/S1359-6349(10)70852-1

Hill V; Hesson L; Dansranjavin T; Dallol A; Bieche I; Tommasi S; Dobbins T; Gentle D; Euhus D; Dammann R; Ward RL; Minna J; Maher ER; Pfeifer G; Latif F, 2010, 'MIRA (methylated CpG island recovery assay) assay identifies frequently methylated genes in breast cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, http://dx.doi.org/10.1158/1538-7445.AM10-165

Metz AJ; Bourke MJ; Moss A; Hesson L; Ward R, 2010, 'A correlation of the endoscopic characteristics of colonic laterally spreading tumours (LSTs) with genetic mutations', Vol. 25, pp. A78 - A78, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200212&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pearson S; Srasuebkul P; Harris C; Ward RL; Dobbins TA; Harris C, 2010, 'Trastuzumab treatment outcomes according to concomitant chemotheray regimen: Overall survival of HER2+ metastatic breast cancer patients', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S187 - S187, presented at Pharmacoepidemiology & Therapeutic Risk Management, Brighton, UK, 19 August 2010 - 22 August 2010, http://dx.doi.org/10.1002/pds

Pearson S; Chin M; Ward RL, 2009, 'The Financially Tolerable Dose: A New Concept in Cancer Trial Design', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S173 - S174, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000269009900396&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Pearson S; Ringland C; Ward RL, 2008, 'Off-label trastuzumab use in Australia: Evidence from the national Herceptin Program for HER-2 positive metastatic breast cancer', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. 66 - 66, presented at Pharmacoepidemiology and Drug Safety

Pearson S; Ringland CL; Ward RL, 2008, 'Off-label trastuzumab use in Australia: Evidence from the national Herceptin Program for HER-2 positive metastatic breast cancer', Vol. 17, pp. S29 - S29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000258420100067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ringland C; Pearson S-A; Ward RL, 2008, 'Survival of women treated with trastuzumab for HER-2-positive metastatic breast cancer: Estimating outcomes in clinical practice using administrative data', Vol. 17, pp. S191 - S192, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000258420100436&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ringland C; Pearson S; Ward RL, 2008, 'Survival of women treated with trastuzumab for HER-2-positive metastatic breast cancer: Estimating outcomes in clinical practice using administrative data', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. 436 - 437, presented at Pharmacoepidemiology and Drug Safety

Rushton S; Bichel-Findlay J; Ward RL; Sinclair S, 2008, 'Using an IT platform to deliver standardised cancer information at the point of care', in HIC 2008 Australia's health informatics conference, HIC 2008 Australia's Health Informatics Conference, Melbourne, Australia, presented at HIC 2008 Australia's Health Informatics Conference, Melbourne, Australia, 01 September 2008

Hitchins MP; Williams R; Suthers G; Suter CM; Cheong K; Halina N; Ap Lin V; Buckle AD; Packham D; Burn J; Scott R; Spigelman AD; Kirk J; Gallinger S; Goldblatt J; Leggett B; Tomlinson IP; Hawkins NJ; Martin DI; Ward RL, 2005, 'The role of MLH1 germ line epimutations in the development of colorectal cancer', presented at International Society for Gastrointestinal Hereditary Tumours, Newcastle, UK

Johnson K; Stokes B; Anthony D; Ward RL; Freemantle N; Hill S, 2005, 'The influence of secular trend and treatment regimen on response rate and time-to-progression surrogates in metastatic colon cancer and non-small-cell lung cancer trials', in Annals of Oncology, Oxford Univ Press, Budapest, HUNGARY, Vol. 16, pp. 282 - 282, presented at ESMO Scientific and Educational Conference (ESEC), Budapest, HUNGARY, 02 June 2005 - 05 June 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000229977400085&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Liauw WS; Segelov E; Lih A; Links MJ; Dunleavy R; Ward RL, 2005, 'Outcomes and utilization patterns of intravenous bisphosphonates for bony metastases in patients with advanced breast cancer: Results in the off-trial setting', in Journal of Clinical Oncology, Jitendar P Vij, Jaypee Brothers Medical Publishers (P) Ltd, Orlando, FL, pp. 550S - 550S, presented at 41st Annual Meeting of the American-Society-of-Clinical-Oncology, Orlando, FL, 13 May 2005 - 17 May 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230326603422&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Tothill RW; Kowalczyk A; Rischin D; Bousioutas A; Haviv I; van Laur RK; Waring PM; Zalcberg J; Ward R; Biankin AV; Sutherland RI; Henshall SM; Fong K; Pollack JR; Bowtell DDL; Holloway AJ, 2005, Expression diagnostic for cancer of unknown primary (vol 65, pg 4031, 2005), AMER ASSOC CANCER RESEARCH, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231659500071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bariol CM; Hawkins NJ; Turner JI; Meagher AP; Williams DB; Ward RL, 2004, 'Histopathological and clinical evaluation of serrated adenomas of the colorectum', Vol. 53, pp. A69 - A69, presented at Annual Meeting of the British-Society-of-Gastroenterology, Glasgow, Scotland, 21 March 2004 - 24 March 2004, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000220584500266&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Bariol CM; Suter CM; Ku S; Cheong F; Meagher AP; Ward RL, 2004, 'Methylation studies in colonic polyps and cancers', in Gut, B M J Publishing Group, London, England, pp. A121 - A121, presented at The British Society of Gastroenterology Annual Meeting, Scottish Exhibition and Conference Centre, Glasgow, 21 March 2004 - 24 March 2004, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000220584500467&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Liauw WS; Ward RL, 2004, 'Utilisation of Markov-Monte Carlo modelling to determine treatmentstrategies in advanced non-small cell lung cancer', in Journal of Clinical Oncology, Jitendar P Vij, Jaypee Brothers Medical Publishers (P) Ltd, New Orleans, LA, pp. 647S - 647S, presented at 40th Annual Meeting of the American-Society-of-Clinical-Oncology, New Orleans, LA, 05 June 2004 - 08 June 2004, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000223512402566&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Libby SB; Tabak M; Hoffman RD; Stoyer MA; Haan SW; Hatchett SP; McNabb DP; Ormand WE; Escher J; Navratil P; Gogny D; Weiss MS; Mustafa M; Backer J; Younes W; Hartouni E; Ward RA, 2004, 'Prospects for investigating unusual nuclear reaction environments using the national ignition facility', in Inertial Fusion Sciences and Applications 2003, pp. 935 - 939

Ward R; Cheong K; Ku S; Hawkins NJ, 2003, 'Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability.', in CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, AMER ASSOC CANCER RESEARCH, ARIZONA, PHOENIX, pp. 1290S - 1290S, presented at 2nd Annual AACR International Conference on Frontiers in Cancer Prevention Research, ARIZONA, PHOENIX, 26 October 2003 - 30 October 2003, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000187153300055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Brown DA; Liu T; Ward RL; Hawkins NJ; Fairlie WD; Bauskin AR; Russell PJ; Quinn DI; Grygiel JJ; Moore AG; Sutherland RL; Turner J; Kingsley EA; Breit SN, 2001, 'Macrophage inhibitory cytokine-1 (MIC-1) in epithelial neoplasia', in JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION AMER SOC EXP BIOL, pp. 90 - 90, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000171482200311&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Suzuki N; Saunders BP; Talbot IC; Tomlinson I; Sawyer E; Ward RL; Brooker JC; Shah SG; Williams CB, 2000, 'Small flat colorectal cancer: Experience in 870 consecutive colonoscopies.', Vol. 51, pp. AB149 - AB149, http://dx.doi.org/10.1016/S0016-5107(00)14337-8

Clark MA; Hawkins NJ; Ward RL, 1997, 'Selection and assay of recombinant antibodies against colorectal tumour antigens', in 9th Lorne Cancer Conference, 9th Lorne Cancer Conference, Lorne, Victoria, pp. 1102 - 1102, presented at 9th Lorne Cancer Conference, Lorne, Victoria, 13 February 1997 - 16 February 1997

Zahra DG; Hawkins NJ; Vancov A; Ward RL, 1997, 'An in vivo recombination strategy using 1oxP-cre to generate large phage display antiBody repertoires', in 9th Lorne Cancer Conference, 9th Lorne Cancer Conference, Lorne, Victoria, pp. E3 - E3, presented at 9th Lorne Cancer Conference, Lorne, Victoria, 13 February 1997 - 16 February 1997

Lord RS; Law MG; Ward RL, 1996, 'Rising incidence of oesophageal adenocarcinoma in men in Australia', in Australian and New Zealand Journal of Surgery, Wiley-Blackwell Publishing Asia, Australia, pp. A44 - A44, presented at ANZ Journal of Surgery: Supp 1, Geelong Hospital, Victoria, 22 August 1996 - 24 August 1996

Ward RL; Clark MA; Papaioannou A; Hawkins NJ, 1996, 'Generation of anti-tumour antibodies using phage display.', in IBC international conference on Antibody engineering, IBC international conference on Antibody engineering, San Diego, California, USA, pp. 211 - 219, presented at IBC international conference on Antibody engineering, San Diego, California, USA, -